<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Dis Model Mech</journal-id>
<journal-id journal-id-type="iso-abbrev">Dis Model Mech</journal-id>
<journal-id journal-id-type="publisher-id">DMM</journal-id>
<journal-id journal-id-type="hwp">dmm</journal-id>
<journal-title-group>
<journal-title>Disease Models &amp; Mechanisms</journal-title>
</journal-title-group>
<issn pub-type="ppub">1754-8403</issn>
<issn pub-type="epub">1754-8411</issn>
<publisher>
<publisher-name>The Company of Biologists Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28993310</article-id>
<article-id pub-id-type="pmc">5665454</article-id>
<article-id pub-id-type="doi">10.1242/dmm.029728</article-id>
<article-id pub-id-type="publisher-id">DMM029728</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rodent models in Down syndrome research: impact and future opportunities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7049-6900</contrib-id>
<name>
<surname>Herault</surname>
<given-names>Yann</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="aff" rid="af4">4</xref>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7227-0921</contrib-id>
<name>
<surname>Delabar</surname>
<given-names>Jean M.</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="aff" rid="af6">6</xref>
<xref ref-type="aff" rid="af7">7</xref>
<xref ref-type="aff" rid="af8">8</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2850-9936</contrib-id>
<name>
<surname>Fisher</surname>
<given-names>Elizabeth M. C.</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="aff" rid="af9">9</xref>
<xref ref-type="aff" rid="af10">10</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2439-0798</contrib-id>
<name>
<surname>Tybulewicz</surname>
<given-names>Victor L. J.</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="aff" rid="af10">10</xref>
<xref ref-type="aff" rid="af11">11</xref>
<xref ref-type="aff" rid="af12">12</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-8152-0790</contrib-id>
<name>
<surname>Yu</surname>
<given-names>Eugene</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="aff" rid="af13">13</xref>
<xref ref-type="aff" rid="af14">14</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-1418-5849</contrib-id>
<name>
<surname>Brault</surname>
<given-names>Veronique</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch</institution>, <addr-line>1 rue Laurent Fries, 67404 Illkirch</addr-line>, <country>France</country></aff>
<aff id="af2"><label>2</label><institution>Centre National de la Recherche Scientifique, UMR7104</institution>, <addr-line>Illkirch</addr-line>, <country>France</country></aff>
<aff id="af3"><label>3</label><institution>Institut National de la Santé et de la Recherche Médicale, U964</institution>, <addr-line>Illkirch</addr-line>, <country>France</country></aff>
<aff id="af4"><label>4</label><institution>Université de Strasbourg</institution>, <addr-line>67404 Illkirch</addr-line>, <country>France</country></aff>
<aff id="af5"><label>5</label><institution>T21 Research Society, Brain and Spine Institute (ICM)</institution>, <addr-line>75013 Paris</addr-line></aff>
<aff id="af6"><label>6</label><institution>Université Paris Diderot, Sorbonne Paris Cité, Unité de Biologie Fonctionnelle et Adaptative, UMR8251, CNRS</institution>, <addr-line>75205 Paris</addr-line>, <country>France</country></aff>
<aff id="af7"><label>7</label><institution>INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et la Moelle épinière, ICM</institution>, <addr-line>75013 Paris</addr-line>, <country>France</country></aff>
<aff id="af8"><label>8</label><institution>Brain and Spine Institute (ICM) CNRS UMR7225, INSERM UMRS 975</institution>, <addr-line>75013 Paris</addr-line>, <country>France</country></aff>
<aff id="af9"><label>9</label><addr-line>Department of Neurodegenerative Disease</addr-line>, <institution>Institute of Neurology, University College London</institution>, <addr-line>London, WC1N 3BG</addr-line>, <country>UK</country></aff>
<aff id="af10"><label>10</label><institution>LonDownS Consortium</institution>, <addr-line>London</addr-line>, <country>W1T 7NF UK</country></aff>
<aff id="af11"><label>11</label><institution>The Francis Crick Institute</institution>, <addr-line>1 Midland Road, London, NW1 1AT</addr-line>, <country>UK</country></aff>
<aff id="af12"><label>12</label><addr-line>Department of Medicine</addr-line>, <institution>Imperial College</institution>, <addr-line>London, SW7 2AZ</addr-line>, <country>UK</country></aff>
<aff id="af13"><label>13</label><addr-line>The Children's Guild Foundation Down Syndrome Research Program, Department of Cancer Genetics and Genetics Program</addr-line>, <institution>Roswell Park Cancer Institute</institution>, <addr-line>Buffalo, NY 14263</addr-line>, <country>USA</country></aff>
<aff id="af14"><label>14</label><addr-line>Department of Cellular and Molecular Biology</addr-line>, <institution>Roswell Park Division of Graduate School, Genetics, Genomics and Bioinformatics Program, State University of New York at Buffalo</institution>, <addr-line>Buffalo, NY 14263</addr-line>, <country>USA</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label>Author for correspondence (<email>herault@igbmc.fr</email>)</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>10</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="ppub"/>. -->
<volume>10</volume>
<issue>10</issue>
<fpage>1165</fpage>
<lpage>1186</lpage>
<permissions>
<copyright-statement>© 2017. Published by The Company of Biologists Ltd</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/3.0</ali:license_ref>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="dmm-10-029728.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Down syndrome is caused by trisomy of chromosome 21. To date, a multiplicity of mouse models with Down-syndrome-related features has been developed to understand this complex human chromosomal disorder. These mouse models have been important for determining genotype-phenotype relationships and identification of dosage-sensitive genes involved in the pathophysiology of the condition, and in exploring the impact of the additional chromosome on the whole genome. Mouse models of Down syndrome have also been used to test therapeutic strategies. Here, we provide an overview of research in the last 15 years dedicated to the development and application of rodent models for Down syndrome. We also speculate on possible and probable future directions of research in this fast-moving field. As our understanding of the syndrome improves and genome engineering technologies evolve, it is necessary to coordinate efforts to make all Down syndrome models available to the community, to test therapeutics in models that replicate the whole trisomy and design new animal models to promote further discovery of potential therapeutic targets.</p>
</abstract>
<abstract abstract-type="precis">
<p><bold>Summary:</bold> Mouse models have boosted therapeutic options for Down syndrome, and improved models are being developed to better understand the pathophysiology of this genetic condition.</p>
</abstract>
<kwd-group>
<title>KEY WORDS</title>
<kwd>Down syndrome</kwd>
<kwd>Mouse model</kwd>
<kwd>Chromosome engineering</kwd>
<kwd>Aneuploidy</kwd>
<kwd>Dosage-senstive gene</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Centre National de la Recherche Scientifique</institution>
<institution-id>http://dx.doi.org/10.13039/501100004794</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Institut National de la Santé et de la Recherche Médicale</institution>
<institution-id>http://dx.doi.org/10.13039/501100001677</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Université de Strasbourg</institution>
<institution-id>http://dx.doi.org/10.13039/501100003768</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>European Commission</institution>
<institution-id>http://dx.doi.org/10.13039/501100000780</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Fifth Framework Programme</institution>
<institution-id>http://dx.doi.org/10.13039/100011104</institution-id>
</institution-wrap>
</funding-source>
<award-id>LSHG-CT-2006-037627</award-id>
<award-id>ANR-10-INBS-07 PHENOMIN</award-id>
<award-id>ANR-10-LABX-0030-INRT</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Agence Nationale de la Recherche</institution>
<institution-id>http://dx.doi.org/10.13039/501100001665</institution-id>
</institution-wrap>
</funding-source>
<award-id>ANR-10-IDEX-0002-02</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Sixth Framework Programme</institution>
<institution-id>http://dx.doi.org/10.13039/100011103</institution-id>
</institution-wrap>
</funding-source>
<award-id>241995</award-id>
<award-id>ANR-09-MNPS-008</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Wellcome Trust</institution>
<institution-id>http://dx.doi.org/10.13039/100004440</institution-id>
</institution-wrap>
</funding-source>
<award-id>080174</award-id>
<award-id>098327</award-id>
<award-id>098328</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Francis Crick Institute</institution>
<institution-id>http://dx.doi.org/10.13039/100010438</institution-id>
</institution-wrap>
</funding-source>
<award-id>FC001194</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Institutes of Health</institution>
<institution-id>http://dx.doi.org/10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>R01NS66072</award-id>
<award-id>R01HL91519</award-id>
<award-id>R21GM114645</award-id>
<award-id>P30CA16056</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Roswell Park Alliance Foundation, Roswell Park Cancer Institute</institution>
<institution-id>http://dx.doi.org/10.13039/100006398</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Fondation Jérôme Lejeune</institution>
<institution-id>http://dx.doi.org/10.13039/501100001673</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Trisomy of human chromosome 21 (Hsa21; see <xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref> for a glossary of terms), which affects 1 in 700 live births globally (<xref ref-type="bibr" rid="DMM029728C34">Canfield et al., 2006</xref>), gives rise to Down syndrome (DS), a condition that significantly impairs health and autonomy of affected individuals (<xref ref-type="bibr" rid="DMM029728C111">Khoshnood et al., 2011</xref>; <xref ref-type="bibr" rid="DMM029728C167">Parker et al., 2010</xref>). Despite the wide availability of prenatal diagnosis since the mid-1960s (<xref ref-type="bibr" rid="DMM029728C220">Summers et al., 2007</xref>) and the introduction of maternal serum screening in 1984 (<xref ref-type="bibr" rid="DMM029728C103">Inglis et al., 2012</xref>), the incidence of DS has not necessarily decreased (<xref ref-type="bibr" rid="DMM029728C155">Natoli et al., 2012</xref>; <xref ref-type="bibr" rid="DMM029728C132">Loane et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C53">de Graaf et al., 2016</xref>); in fact, prevalence is going up, largely because of increased lifespan and maternal age (which is the single biggest risk factor) (<xref ref-type="bibr" rid="DMM029728C206">Sherman et al., 2007</xref>; <xref ref-type="bibr" rid="DMM029728C132">Loane et al., 2013</xref>).
<boxed-text id="DMM029728B1" orientation="portrait" position="float"><caption><title>Box 1. Glossary</title></caption><p><bold>Aneuploid:</bold> having an abnormal or unbalanced number of chromosomes.</p><p><bold>Cardiac septation:</bold> partitioning of the heart.</p><p><bold>Contextual and auditory-cue-conditioned fear task:</bold> a test to study associative memory based on the association of environmental cues (the chamber for the context or a sound for the auditory cue) with an aversive stimulus (a light electric shock). The association of both stimuli will lead to a freezing, with almost no movement of the animal tested. Recording the percentage of immobility of the mouse after being placed backed in the environment or with the auditory cue 24 h after the shock gives an assessment of the associative memory.</p><p><bold>Euploid:</bold> having a normal balanced number of chromosomes.</p><p><bold>Hypotonia:</bold> a state of low muscle tone.</p><p><bold>Long-term potentiation (LTP):</bold> an increase in synaptic response after high-frequency stimulation of neurons. A strategy used to test the plasticity and the consolidation of synapses.</p><p><bold>Morris water maze:</bold> a test to study spatial memory, based on the normal behaviour of a mouse to exit a water maze using an external visual cue located outside a pool in which a small platform is hidden below the surface of the water. The path with the distance travelled and the time spent to reach the platform is indicative of function of spatial memory.</p><p><bold>Mosaic:</bold> animal carries cells with different genotypes.</p><p><bold>Novel-object recognition</bold>: a test to study non-spatial episodic memory based on the normal interest of the animal in exploring objects in its environment (an open field). The test evaluates recognition memory for previously explored objects by measuring the time spent sniffing a known versus a novel object.</p><p><bold>Positive thigmotaxis:</bold> a behavioural preference displayed by some animals to be near or in close contact with the solid wall of an enclosure. The time spent in contact or close to the vertical wall of the open field is measured, in the exploration of a new environment.</p><p><bold>Transchromosomic</bold>: a transgenic animal carrying a chromosome from a different species.</p><p><bold>Trisomy:</bold> having a third copy of a given chromosome. Trisomy is associated with a number of human disorders, including Down syndrome.</p><p><bold>Ventriculomegaly:</bold> enlargement or dilation of lateral brain ventricles.</p><p><bold>Y-maze:</bold> a test involving a maze with three arms, which provides the animal with a choice: to visit the arm visited before or go to a new arm. This is a test that measures working memory.</p></boxed-text></p>
<p>A core set of features characterises most cases of DS, including specific cognitive disabilities, hypotonia (<xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>) at birth and characteristic craniofacial changes; however, other traits, such as cardiac defects and susceptibility to leukemias, affect only a subset of individuals with DS (OMIM 190685; ORPHA870). Later in life, the majority of DS individuals will develop Alzheimer's disease (AD; approximately 60% by the age of 65), making trisomy 21 the most common genetic cause of this neurodegenerative disease (<xref ref-type="bibr" rid="DMM029728C13">Ballard et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C57">Dekker et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C92">Head et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C237">Wiseman et al., 2015</xref>).</p>
<p>The phenotypes observed in DS are likely to arise because of dosage sensitivity of Hsa21 genes and associated gene-environment interactions (<xref ref-type="bibr" rid="DMM029728C9">Antonarakis et al., 2004</xref>; <xref ref-type="bibr" rid="DMM029728C8">Antonarakis, 2016</xref>; <xref ref-type="bibr" rid="DMM029728C15">Beach et al., 2017</xref>), and/or a global effect of the extra chromosome on chromatin regulation and methylation (<xref ref-type="bibr" rid="DMM029728C125">Letourneau et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C96">Hervé et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C145">Mendioroz et al., 2015</xref>). Studies of patients carrying rare segmental duplications of Hsa21 subregions have highlighted the role of specific chromosomal regions in DS pathophysiology (<xref ref-type="bibr" rid="DMM029728C116">Korbel et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C117">Korenberg et al., 1994</xref>; <xref ref-type="bibr" rid="DMM029728C136">Lyle et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C58">Delabar et al., 1993</xref>). In addition, studies using animal models have confirmed the involvement of homologous regions and shown how some regions with orthologues of individual Hsa21 dosage-sensitive genes are key for DS features (discussed in detail below). A few genes not located on Hsa21 have been shown to contribute to individual phenotypic variation (<xref ref-type="bibr" rid="DMM029728C189">Roper and Reeves, 2006</xref>). Analysis of individuals with a segmental duplication of Hsa21 has been key to building up a phenotypic map and defining a critical DS region (<xref ref-type="bibr" rid="DMM029728C58">Delabar et al., 1993</xref>; <xref ref-type="bibr" rid="DMM029728C136">Lyle et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C116">Korbel et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C117">Korenberg et al., 1994</xref>; <xref ref-type="bibr" rid="DMM029728C178">Rahmani et al., 1989</xref>). Nevertheless, with only about 60 duplications reported so far in the literature, the resolution of this map is very low. Moreover, duplications that do not induce strong phenotypes, or that lead to embryonic death, are not represented in published studies (<xref ref-type="bibr" rid="DMM029728C192">Rovelet-Lecrux et al., 2006</xref>). A more detailed understanding of the DS genotype-phenotype relationship in humans would require a systematic analysis of very large numbers of individuals and of stillborns. Indeed, 31-54% of DS pregnancies lead to spontaneous foetal loss (<xref ref-type="bibr" rid="DMM029728C132">Loane et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C152">Morris et al., 1999</xref>; <xref ref-type="bibr" rid="DMM029728C151">Morris and Wald, 2007</xref>).</p>
<p>This Review focuses on the use of rodent models of DS, which have been essential for the determination of genotype-phenotype relationships for this syndrome. Owing to the genetic tractability of this animal, the most useful DS models to date have been derived from the laboratory mouse. Mice are highly amenable to genome engineering, including through chromosome engineering, to generate precisely defined large genomic segmental duplications to model chromosomal disorders (<xref ref-type="bibr" rid="DMM029728C30">Brault et al., 2006</xref>; <xref ref-type="bibr" rid="DMM029728C243">Yu and Bradley, 2001</xref>; <xref ref-type="bibr" rid="DMM029728C179">Ramirez-Solis et al., 1995</xref>; <xref ref-type="bibr" rid="DMM029728C94">Hérault et al., 1998</xref>; <xref ref-type="bibr" rid="DMM029728C230">Tybulewicz and Fisher, 2006</xref>). Mouse models have also provided platforms for testing interactions between cell and tissue types, responses in the organism, and candidate therapeutics for DS. We highlight the approaches and technologies that have been used to generate mouse models of DS in recent years, and also discuss how the study of these models has brought new knowledge about DS pathophysiology, including key candidate pathways and genes, as well as providing new therapeutic approaches.</p>
</sec>
<sec id="s2">
<title>Building up a compendium of DS models</title>
<p>The rapid development of genetic engineering in recent years has stimulated the generation of multiple DS mouse models. A variety of transgenic models for candidate genes were developed in early attempts at modelling DS in mice (<xref ref-type="bibr" rid="DMM029728C61">Dierssen et al., 2009</xref>), and we discuss such experiments briefly in a later section. Here, we discuss DS mouse models that contain larger trisomic or duplicated chromosomal segments, thereby mimicking the trisomy observed in humans.</p>
<sec id="s2a">
<title>Early mouse models of trisomy 21</title>
<p>Over the approximately 75-million years that separate humans and mice in evolutionary time, the chromosomes have rearranged such that Hsa21 has three orthologous regions on mouse chromosomes 10, 16, 17 in which gene order and orientation are conserved (Mmu10, 16, 17; Mmu for <italic>Mus musculus</italic>; <xref ref-type="fig" rid="DMM029728F1">Fig. 1</xref>). Hsa21 carries 222 protein-coding genes, including 49 that encode keratin-associated proteins and are clustered on Hsa21q, and 325 non-protein-coding genes (<xref ref-type="bibr" rid="DMM029728C86">Gupta et al., 2016</xref>). Of the 158 mouse genes that are homologous to human protein-coding genes, most of them lie on Mmu16 (a total of 102) between <italic>Lipi</italic> and <italic>Zbtb21</italic>, a few on Mmu17 (19) between <italic>Abcg1</italic> and <italic>Rrp1b</italic>, and the rest on Mmu10 (37) between <italic>Pdxk</italic> and <italic>Prmt2</italic>. Of the non-coding genes, 75 elements, such as those encoding miRNAs, are well conserved and are distributed across all three mouse chromosomes (<xref ref-type="bibr" rid="DMM029728C86">Gupta et al., 2016</xref>). Because the equivalent genetic elements are distributed between regions on three different chromosomes, modelling trisomy 21 in the mouse is not straightforward (<xref ref-type="bibr" rid="DMM029728C9">Antonarakis et al., 2004</xref>). In addition, a handful of human genes [such as the prostate-, ovary-, testis- and placenta-expressed ankyrin domain family member D (<italic>POTED</italic>)] are not conserved in the mouse, and there are mouse genes, such as integrin beta-2-like (<italic>Itgb2l</italic>) located between <italic>Igsf5</italic> and <italic>Pcp4</italic> in the Hsa21 homologous regions, that have no human homologues. Furthermore, we do not yet have a clear picture of the role and function (if any) of many pseudogenes (<xref ref-type="bibr" rid="DMM029728C86">Gupta et al., 2016</xref>).
<fig id="DMM029728F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p><bold>Mouse models of DS.</bold> Human chromosome 21 (p and q arms; G-banding) is depicted at the top of the figure, with the mouse genome orthologous region found on chromosome 16 (Mmu16), Mmu10 and Mmu17 shown respectively in orange, light green and red. A few known genes that are homologous to Hsa21 genes in the DS critical region are listed below each chromosome. The transchromosomic Tc1 mouse model is shown in dark green, with deletions and a duplication (double bar) relative to Hsa21 depicted. Below, the segment of the DS critical region encompassed in different mouse models for DS is illustrated. The original Ts65Dn (<xref ref-type="bibr" rid="DMM029728C182">Reeves et al., 1995</xref>) and Ts1Cje (<xref ref-type="bibr" rid="DMM029728C199">Sago et al., 1998</xref>) models (shown in brown) originated by accidental translocation of Mmu16 segments respectively on Mmu17 and Mmu12, with some additional changes (<xref ref-type="bibr" rid="DMM029728C67">Duchon et al., 2011b</xref>; <xref ref-type="bibr" rid="DMM029728C184">Reinholdt et al., 2011</xref>). <xref ref-type="bibr" rid="DMM029728C161">Olson et al. (2004)</xref> published the first engineered duplication (Dp) and deletion [deficiency (Df)] for the DS critical region (light blue). New models have been developed in the last 10 years by the authors of this Review, as shown in dark blue (<xref ref-type="bibr" rid="DMM029728C66">Duchon et al., 2011a</xref>; <xref ref-type="bibr" rid="DMM029728C135">Lopes Pereira et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C21">Besson et al., 2007</xref>; <xref ref-type="bibr" rid="DMM029728C139">Marechal et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C200">Sahun et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C180">Raveau et al., 2012</xref>; <xref ref-type="bibr" rid="DMM029728C10">Arbogast et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C33">Brault et al., 2015b</xref>), red (<xref ref-type="bibr" rid="DMM029728C105">Jiang et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C129">Liu et al., 2011</xref>, <xref ref-type="bibr" rid="DMM029728C130">2014</xref>; <xref ref-type="bibr" rid="DMM029728C244">Yu et al., 2010a</xref>,<xref ref-type="bibr" rid="DMM029728C245">b</xref>,<xref ref-type="bibr" rid="DMM029728C246">c</xref>; <xref ref-type="bibr" rid="DMM029728C126">Li et al., 2007</xref>) and green (<xref ref-type="bibr" rid="DMM029728C122">Lana-Elola et al., 2016</xref>). TgBACs, a few models for BAC or PAC (P1-derived artificial chromosome) transgenic lines.</p></caption><graphic xlink:href="dmm-10-029728-g1"></graphic></fig></p>
<p>Early modelling was attempted by studying mice with full trisomy of mouse 16 (<xref ref-type="bibr" rid="DMM029728C81">Gropp et al., 1975</xref>; <xref ref-type="bibr" rid="DMM029728C80">Gropp, 1974</xref>). These animals have numerous defects, including, for example, cardiac septation deficits (<xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>) (<xref ref-type="bibr" rid="DMM029728C236">Webb et al., 1999</xref>); however, they do not model DS because the majority of genes that are triplicated in this model are from regions of Mmu16 without homology to Hsa21. Furthermore, these animals die at birth and so cannot give insight into processes beyond this stage.</p>
<p>The field of DS investigation moved forward by the discovery in 1990 and the phenotypic description in 1995 of the Ts65Dn mouse (<xref ref-type="fig" rid="DMM029728F1">Fig. 1</xref>) (<xref ref-type="bibr" rid="DMM029728C182">Reeves et al., 1995</xref>; <xref ref-type="bibr" rid="DMM029728C52">Davisson et al., 1990</xref>). This mouse has a translocation that results in an extra-small chromosome made up of a fusion of the <italic>App-Zbtb21</italic> region orthologous to Hsa21 found on Mmu16 with the centromeric region of Mmu17; thus, the mouse shows aneuploidy (<xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>). The extra region of Mmu16 includes 90 conserved protein-coding Hsa21 gene orthologues (<xref ref-type="bibr" rid="DMM029728C39">Choong et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C86">Gupta et al., 2016</xref>). The Ts65Dn mouse was the main model used to study DS for at least two decades and has provided many new insights (see below). However, the animal carries three copies of an extra segment (arising from Mmu17) with non-DS-related genes, including ∼35 protein-coding genes, 15 non-protein-coding genes and 10 pseudogenes (<xref ref-type="bibr" rid="DMM029728C67">Duchon et al., 2011b</xref>; <xref ref-type="bibr" rid="DMM029728C184">Reinholdt et al., 2011</xref>). Moreover, even though some Ts65Dn males are fertile (<xref ref-type="bibr" rid="DMM029728C148">Moore et al., 2010</xref>), transmission is usually achieved through the maternal germline. This might affect the phenotype of the trisomic progeny and their disomic littermates because the mothers are trisomic, generally unlike the situation in humans.</p>
<p>Other models of partial trisomy 16, the Ts1Cje (trisomic for the <italic>Sod1</italic>-<italic>Zbtb21</italic> region, shown in <xref ref-type="fig" rid="DMM029728F1">Fig. 1</xref>) and the Ts2Cje (harbours a Robertsonian translocation between the extra chromosome in Ts65Dn and mouse chromosome 12) (<xref ref-type="fig" rid="DMM029728F1">Fig. 1</xref>, <xref ref-type="table" rid="DMM029728TB1">Table 1</xref>), have made important contributions to our understanding of DS. Nevertheless, as with Ts65Dn, they were generated by chance rather than design, and carry additional genetic modifications that could have an impact on phenotypes (<xref ref-type="bibr" rid="DMM029728C199">Sago et al., 1998</xref>; <xref ref-type="bibr" rid="DMM029728C235">Villar et al., 2005</xref>).
<table-wrap id="DMM029728TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p><bold>Mouse models of DS</bold></p></caption><graphic xlink:href="dmm-10-029728-i1"></graphic></table-wrap></p>
</sec>
<sec id="s2b">
<title>Advances in engineering DS mouse models</title>
<p>The field of DS modelling in mice changed significantly in the mid-2000s with the advent of two new types of mice: one that is transchromosomic (<xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>) and those that are chromosome engineered.</p>
<p>In 2005, V.L.J.T., E.M.C.F. and colleagues published the first transchromosomic mouse line (<xref ref-type="bibr" rid="DMM029728C158">O'Doherty et al., 2005</xref>), namely Tc1 [formally called Tc(Hsa21)1TybEmcf]. The line was generated using irradiation microcell-mediated chromosome transfer into embryonic stem (ES) cells, leading to a freely segregating copy of Hsa21, transmitted through the germline. In Tc1, human Hsa21 sequences are expressed in the mouse at the mRNA, protein and functional levels (<xref ref-type="bibr" rid="DMM029728C1">Ahmed et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C185">Reynolds et al., 2010</xref>; <xref ref-type="bibr" rid="DMM029728C158">O'Doherty et al., 2005</xref>). For example, targeting the overexpressed transcripts encoded by four genes restored VEGF-dependent normal angiogenic responses in Tc1 mice (<xref ref-type="bibr" rid="DMM029728C185">Reynolds et al., 2010</xref>). However, the human chromosome is lost stochastically from cells, and so the resulting mice are mosaics (<xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>): some cells carry the supernumerary Hsa21, whereas others do not. Also, complete sequencing of the human chromosome (<xref ref-type="bibr" rid="DMM029728C79">Gribble et al., 2013</xref>) has revealed that it was rearranged in the process, probably due to γ-ray-induced <italic>de novo</italic> rearrangements, leading to incomplete trisomy. Nevertheless, this mouse remains a unique complement to the models that help us to understand DS and has given insight into the condition (<xref ref-type="bibr" rid="DMM029728C89">Hall et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C170">Peiris et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C173">Powell et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C238">Witton et al., 2015</xref>).</p>
<p>In the mid-1990s, an approach to generate precise chromosomal rearrangements, including duplications and deletions, was developed in mice (<xref ref-type="bibr" rid="DMM029728C179">Ramirez-Solis et al., 1995</xref>). This technology has radically expanded the available mouse resources for understanding DS by facilitating the design of partial trisomies (<xref ref-type="bibr" rid="DMM029728C243">Yu and Bradley, 2001</xref>; <xref ref-type="bibr" rid="DMM029728C161">Olson et al., 2004</xref>) and producing the most complete model we have: the triple trisomic mouse. This mouse is partially trisomic for the Mmu10, 16 and 17 regions that are homologous to Hsa21 (<xref ref-type="bibr" rid="DMM029728C245">Yu et al., 2010b</xref>). Briefly, the desired chromosomal rearrangement is first engineered in mouse ES cells with two steps of gene targeting to introduce <italic>loxP</italic> sites upstream and downstream of the region of interest with selectable markers, and one additional step leading to the reconstruction of a selectable minigene after Cre expression (<xref ref-type="fig" rid="DMM029728F2">Fig. 2</xref>). A specific orientation of <italic>loxP</italic> targeted on a chromosome must be achieved by appropriate design to induce the chromosomal change. Identification of ES cell clones harbouring an engineered chromosomal rearrangement is facilitated by positive selection of expression of the minigene. Chromosomal duplications and deletions can be precisely verified by Southern blot analysis, fluorescence <italic>in situ</italic> hybridisation, array-based comparative genome hybridisation or whole-genome sequencing (<xref ref-type="bibr" rid="DMM029728C245">Yu et al., 2010b</xref>; <xref ref-type="bibr" rid="DMM029728C79">Gribble et al., 2013</xref>). Selected ES cells are used to establish the corresponding mouse line. Alternatively, recombination between <italic>loxP</italic> sites can be achieved <italic>in vivo</italic> (<xref ref-type="bibr" rid="DMM029728C31">Brault et al., 2007</xref>; <xref ref-type="bibr" rid="DMM029728C94">Hérault et al., 1998</xref>) in a mouse carrying the two <italic>loxP</italic> sites and one specific Cre driver expressed in the germline. In this case, no additional construct is needed at the frontier of the recombined fragments, minimising potential interference associated with the reconstruction of a minigene. Altogether, these Cre/<italic>loxP</italic>-based technologies, carried out independently in two laboratories, resulted in the generation of several mouse models with segmental duplications encompassing different segments of the mouse chromosomes orthologous to Hsa21 (<xref ref-type="bibr" rid="DMM029728C95">Hérault et al., 2012</xref>).
<fig id="DMM029728F2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p><bold>Cre-<italic>loxP</italic>-mediated chromosomal engineering in mice.</bold> A <italic>loxP</italic> site (arrow) is targeted into the first endpoint of the engineered segment (blue) in the embryonic stem (ES) cell genome with a positive selectable marker, such as <italic>neo</italic> (the neomycin-resistance gene; N). Next, a second <italic>loxP</italic> site is targeted to the other endpoint with another positive selectable marker such as <italic>puro</italic>, the puromycin resistance gene (P). A Cre expression vector is then transferred by electroporation into double-targeted ES cell clones. If two <italic>loxP</italic> sites are targeted onto the same chromosome homologue and oriented in the same direction (<italic>cis</italic>), recombination between the sites will lead to a deletion (Df; A). If two <italic>loxP</italic> sites are targeted onto two separate homologues and oriented in the same direction (<italic>trans</italic>), the recombination will lead to a duplication (Dp) and the reciprocal deletion (Df) (B).</p></caption><graphic xlink:href="dmm-10-029728-g2"></graphic></fig></p>
<p>The crucial step needed for inserting <italic>loxP</italic> sites is now facilitated using recombinant transposon-mediated insertion and further selection (<xref ref-type="bibr" rid="DMM029728C38">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C197">Ruf et al., 2011</xref>). In addition, <italic>loxP</italic> site insertions in the mouse genome generated by transposition have been captured in the TRACER resource with precise location and orientation (<uri xlink:href="http://tracerdatabase.embl.de">http://tracerdatabase.embl.de</uri>), reducing the time needed to generate new DS models to 3 years (<xref ref-type="bibr" rid="DMM029728C38">Chen et al., 2013</xref>).</p>
<p>However, a major revolution is now underway with the development of an even faster method – CRISPR-mediated rearrangement (CRISMERE) – which is based on CRISPR/Cas9 genome-editing technology (<xref ref-type="bibr" rid="DMM029728C24">Birling et al., 2017</xref>). Two pairs of small guide RNA (sgRNA), each pair selected either upstream or downstream of the region of interest, are injected with the Cas9 nuclease into one-cell mouse embryos that are reimplanted. Newborns are analysed for chromosomal modifications and are bred to select carrier individuals with the new rearrangement in the next generation. The making of <italic>in vivo</italic> duplications, deletions and inversions of genomic segments of up to 34 Mb using CRISMERE requires less time than it takes to observe germline transmission of recombined ES cells. CRISMERE is not limited to the mouse and has been successfully used in rats (<xref ref-type="table" rid="DMM029728TB1">Table 1</xref>) (<xref ref-type="bibr" rid="DMM029728C24">Birling et al., 2017</xref>) and can be applied to primates. In the rat (<italic>Rattus norvegicus</italic>) genome, the Hsa21 homologous regions are located on two chromosomes, Rno11 and Rno20. On Rno11, the <italic>Lipi-Zbtb21</italic> segment is almost identical to the homologous region located on the Mmu16, whereas Rno20 harbours a unique segment for the <italic>Umodl1</italic>-<italic>Prmt2</italic> interval (<xref ref-type="fig" rid="DMM029728F1">Fig. 1</xref>). Using CRISMERE, new models encompassing both regions have been generated (<xref ref-type="bibr" rid="DMM029728C24">Birling et al., 2017</xref>). These models have the potential to facilitate testing of therapies in both mouse and rat models to enable stronger validation prior to assessment in clinical trials.</p>
<p>Nowadays, the development of DS models is no longer limited at the technical level but rather more at the conceptual level, i.e. in terms of the challenges associated with precise delineation of the region of interest for a particular phenotype. A key question is whether it is better to define smaller regions of interest and generate more models or make models for larger segments to recapitulate the human trisomy. In any case, enhancing our understanding of the link between phenotype and genotype is critical, as discussed below.</p>
</sec>
</sec>
<sec id="s3">
<title>Assessing the genotype-phenotype relationship in DS</title>
<p>Many DS features show variable penetrance (<uri xlink:href="http://omim.org/entry/190685#clinicalFeatures">http://omim.org/entry/190685#clinicalFeatures</uri>) (<xref ref-type="bibr" rid="DMM029728C119">Kruszka et al., 2017</xref>; <xref ref-type="bibr" rid="DMM029728C188">Roizen and Patterson, 2003</xref>). Understanding the molecular basis of this huge variability between individuals could inform the development of therapies to modulate specific features of the syndrome. Variability in DS includes the degree of learning difficulties observed – in 39.4% of cases, IQ typically ranges between 50 and 70, but 1% of affected individuals have an IQ around the borderline function range of 70-80 (<xref ref-type="bibr" rid="DMM029728C9">Antonarakis et al., 2004</xref>). The presence of cardiac anomalies, and the incidence of leukaemia, autoimmune diseases, AD pathology and dementia, as well as accelerated ageing, are also quite variable (<xref ref-type="bibr" rid="DMM029728C9">Antonarakis et al., 2004</xref>). In order to better understand the physiopathology of the disease and to correlate genotype with the features observed in patients, studies in animal models and particularly mouse models have been critical (<xref ref-type="bibr" rid="DMM029728C86">Gupta et al., 2016</xref>).</p>
<p>One of the first consequences of DS is the alteration of embryonic development, leading at the extreme to gestational loss in humans (<xref ref-type="bibr" rid="DMM029728C132">Loane et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C152">Morris et al., 1999</xref>; <xref ref-type="bibr" rid="DMM029728C151">Morris and Wald, 2007</xref>). This phenotype is also observed in Tc1 mice, in Dp1Yey and Dp1Tyb mice (generated in two independent groups), which duplicate the region from <italic>Lipi</italic> to <italic>Zbtb21</italic> (<xref ref-type="fig" rid="DMM029728F1">Fig. 1</xref>), in the Ts65Dn mouse, and to some extent in the Ts1Cje mouse (<xref ref-type="bibr" rid="DMM029728C10">Arbogast et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C180">Raveau et al., 2012</xref>; <xref ref-type="bibr" rid="DMM029728C245">Yu et al., 2010b</xref>; <xref ref-type="bibr" rid="DMM029728C126">Li et al., 2007</xref>; <xref ref-type="bibr" rid="DMM029728C84">Guedj et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C122">Lana-Elola et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C158">O'Doherty et al., 2005</xref>). Reducing the dosage of the 7.7 Mb <italic>App-Runx1</italic> region, containing 54 protein-coding genes and 25 keratin genes, in Ts65Dn mice rescued impaired postnatal viability, and deletion of this region resulted in severe phenotypes and lowered viability, suggesting the presence of critical genes in the interval (<xref ref-type="bibr" rid="DMM029728C10">Arbogast et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C180">Raveau et al., 2012</xref>).</p>
<p>In light of the characteristic intellectual deficiency in human DS, many types of learning and memory have been monitored in DS mouse models to explore which part of the brain is affected by the trisomy (<xref ref-type="bibr" rid="DMM029728C50">Das and Reeves, 2011</xref>; <xref ref-type="bibr" rid="DMM029728C86">Gupta et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C241">Xing et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C19">Belichenko et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C105">Jiang et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C247">Zhang et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C10">Arbogast et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C33">Brault et al., 2015b</xref>; <xref ref-type="bibr" rid="DMM029728C139">Marechal et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C200">Sahun et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C95">Hérault et al., 2012</xref>). The open-field (OF) test (<xref ref-type="bibr" rid="DMM029728C218">Stanford, 2007</xref>) has been used in these studies to assay locomotor activity, exploration and anxiety. Episodic memory (involving the perirhinal cortex and the hippocampus) was a particular focus, with tests for non-spatial learning such as the novel-object recognition (NOR; <xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>) applied with two retention times: 1 h or 24 h (<xref ref-type="bibr" rid="DMM029728C41">Cohen and Stackman, 2015</xref>). Short-term working memory was assessed with continuous spontaneous alternation behaviour mostly using the Y-maze test (<xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>) (<xref ref-type="bibr" rid="DMM029728C97">Hughes, 2004</xref>). Spatial memory, which involves several regions of the brain (hippocampus, striatum, basal forebrain, cerebellum and cerebral cortex), has been explored in DS mice using the Morris water maze (MWM; <xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>) test (<xref ref-type="bibr" rid="DMM029728C59">D'Hooge and De Deyn, 2001</xref>; <xref ref-type="bibr" rid="DMM029728C150">Morris, 1984</xref>). For associative memory, the contextual and auditory-cue-conditioned fear task [FC (fear conditioning); <xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>] (<xref ref-type="bibr" rid="DMM029728C169">Paylor et al., 1994</xref>; <xref ref-type="bibr" rid="DMM029728C142">Mátyás et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C124">Lee et al., 2011</xref>) was used to test the connection between the hippocampus, frontal cortex, cingulate cortex and amygdala and the mediodorsal thalamic nucleus. These studies point to an important role for <italic>DYRK1A</italic> (discussed in the section below). <italic>DYRK1A</italic>, the mammalian orthologue of <italic>Drosophila minibrain kinase (mnb)</italic> (<xref ref-type="bibr" rid="DMM029728C223">Tejedor et al., 1995</xref>), encodes a proline/arginine-directed dual-specificity kinase, and is overexpressed both in the brain of trisomic mice and of individuals with DS (<xref ref-type="bibr" rid="DMM029728C63">Dowjat et al., 2007</xref>). Three copies of <italic>Dyrk1a</italic> are necessary and sufficient to induce several deficits in NOR (at 1 and 24 h) and FC, but only result in delayed learning in the MWM (<xref ref-type="bibr" rid="DMM029728C71">García-Cerro et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C172">Pons-Espinal et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C60">Dierssen and de Lagrán, 2006</xref>; <xref ref-type="bibr" rid="DMM029728C5">Altafaj et al., 2001</xref>; <xref ref-type="bibr" rid="DMM029728C64">Duchon and Herault, 2016</xref>). Interestingly, the Ts1Rhr trisomy mouse, which is trisomic for the DS critical region with 33 genes including <italic>Dyrk1a</italic>, displayed deficits in the OF test and in NOR, with 24 h of retention (<xref ref-type="bibr" rid="DMM029728C18">Belichenko et al., 2009</xref>); additionally, trisomy of this region was necessary to alter spatial memory in Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C162">Olson et al., 2007</xref>). In Ts65Dn, Ts1Cje and Ts1Rhr mice, long-term potentiation (LTP; <xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>), a measure of synaptic plasticity, could be induced only after blocking GABA(A)-dependent inhibitory neurotransmission in the fascia dentata, a structure that receives inputs from the perirhinal cortex (<xref ref-type="bibr" rid="DMM029728C18">Belichenko et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C115">Kleschevnikov et al., 2012b</xref>); this result is indicative of excessive neuronal inhibition and is consistent with previous observations of Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C115">Kleschevnikov et al., 2012b</xref>; <xref ref-type="bibr" rid="DMM029728C69">Fernandez et al., 2007</xref>). In addition, widespread enlargement of dendritic spines and decreased density of spines in the fascia dentata were observed, which could explain the overall reduced activation of neuronal activity (<xref ref-type="bibr" rid="DMM029728C18">Belichenko et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C88">Haas et al., 2013</xref>). Thus, cognitive impairment in DS seems to derive from molecular and structural changes related to an altered copy number within this 33-gene region. This conclusion was confirmed when combining Dp1Yey mice either with deletion of the <italic>Std4-KcnJ6</italic> interval or <italic>Kcnj15-Mx2</italic>, which showed that both regions contain dosage-sensitive genes contributing to cognitive phenotypes (<xref ref-type="bibr" rid="DMM029728C105">Jiang et al., 2015</xref>).</p>
<p>The Ts65Dn mouse model also displays lower performance in finding a hidden platform compared to controls in the MWM task at 4 months of age (<xref ref-type="bibr" rid="DMM029728C182">Reeves et al., 1995</xref>; <xref ref-type="bibr" rid="DMM029728C156">Netzer et al., 2010</xref>; <xref ref-type="bibr" rid="DMM029728C160">Olmos-Serrano et al., 2016b</xref>), but this phenotype is not consistently observed in 2- to 4-month-old Dp1Yey mice (<xref ref-type="bibr" rid="DMM029728C246">Yu et al., 2010c</xref>; <xref ref-type="bibr" rid="DMM029728C74">Goodliffe et al., 2016</xref>). Nevertheless, learning is impaired for both models in a variant of the MWM test at the age of 2-3 months (<xref ref-type="bibr" rid="DMM029728C74">Goodliffe et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C159">Olmos-Serrano et al., 2016a</xref>). Overall, the results obtained from these studies are difficult to compare owing to differences in age of tested individuals and more importantly in the protocols or the genetic background used. Thus, there is a strong need to better standardise experimental protocols to allow for more equivalent cross-laboratory comparisons.</p>
<p>Another important point is that combining models with different segmental trisomies can alter the phenotypic outcomes (<xref ref-type="bibr" rid="DMM029728C105">Jiang et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C66">Duchon et al., 2011a</xref>; <xref ref-type="bibr" rid="DMM029728C71">García-Cerro et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C201">Salehi et al., 2006</xref>). Studies in such mice strengthen the evidence for the multigenic nature of DS, already pointed to in human genetic studies (<xref ref-type="bibr" rid="DMM029728C116">Korbel et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C117">Korenberg et al., 1994</xref>; <xref ref-type="bibr" rid="DMM029728C136">Lyle et al., 2009</xref>), with multiple genes interacting to induce the frequently observed intellectual disability that characterises DS. One of the main conclusions is that the hippocampus is a key hub whose dysfunction is observed in many DS mouse models, altering many types of memory, including, for example, the function of the place cells, a type of hippocampal pyramidal neuron that acts to define a cognitive map needed for spatial memory (<xref ref-type="bibr" rid="DMM029728C238">Witton et al., 2015</xref>).</p>
<p>DS universally causes the typical plaques and tangles of AD to appear in the brain by the age of 40, and current figures show that two-thirds of people with DS develop dementia by the age of 60 (<xref ref-type="bibr" rid="DMM029728C237">Wiseman et al., 2015</xref>). Individuals with DS develop Alzheimer's-like pathologies comparatively early in life, including progressive degeneration of basal forebrain cholinergic neurons (BFCNs). The Ts65Dn mouse model exhibits elevated levels of β-amyloid (Aβ) peptide, as well as atrophy of BFCNs. Although the mechanisms are not yet fully understood, the appearance of the pathology almost certainly arises from overexpression of the Hsa21 gene <italic>APP</italic>, which is known to cause early-onset AD when present in three copies, as shown in very rare families with small internal chromosomal duplications that include this gene (<xref ref-type="bibr" rid="DMM029728C193">Rovelet-Lecrux et al., 2007</xref>, <xref ref-type="bibr" rid="DMM029728C192">2006</xref>). In line with this hypothesis, <italic>App</italic> triplication is necessary for the age-dependent BFCN loss observed in the Ts65Dn mouse (<xref ref-type="bibr" rid="DMM029728C201">Salehi et al., 2006</xref>; <xref ref-type="bibr" rid="DMM029728C75">Granholm et al., 2000</xref>) and for neuronal abnormalities in the endosomal compartment, also reported in these mice (<xref ref-type="bibr" rid="DMM029728C36">Cataldo et al., 2008</xref>, <xref ref-type="bibr" rid="DMM029728C35">2000</xref>).</p>
<p>Intriguingly, not everyone with DS develops dementia, although all individuals with DS over the age of 40 show evidence of amyloid plaques. Individuals with duplicated <italic>APP</italic> have dementia onset that is fully penetrant, between 39 to 64 years of age (<xref ref-type="bibr" rid="DMM029728C237">Wiseman et al., 2015</xref>). Conversely, individuals with DS (and thus <italic>APP</italic> in triplicate) show a wide range in age-of-onset of dementia, and can live into their 70s with no sign of dementia (<xref ref-type="bibr" rid="DMM029728C108">Karmiloff-Smith et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C118">Krinsky-McHale et al., 2008</xref>; <xref ref-type="bibr" rid="DMM029728C72">Ghezzo et al., 2014</xref>). Thus, it seems likely that there are also protective factors for AD on Hsa21, and these might be important for understanding and treating dementia in the euploid (<xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>) population. Although the genes involved in modulating AD phenotypes remain to be determined, crosses of different types of AD and DS mouse models to humanised APP will give insight into molecular processes (<xref ref-type="bibr" rid="DMM029728C39">Choong et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C90">Hamlett et al., 2016</xref>).</p>
<p>Insights into congenital heart defects (CHDs) in DS have also been gained using mouse models. In humans, 40% of DS newborns present with a CHD (<xref ref-type="bibr" rid="DMM029728C9">Antonarakis et al., 2004</xref>). In mice, CHDs were observed during development in Tc1 (<xref ref-type="bibr" rid="DMM029728C158">O'Doherty et al., 2005</xref>), Ts65Dn (<xref ref-type="bibr" rid="DMM029728C147">Moore, 2006</xref>), Dp1Yey (<xref ref-type="bibr" rid="DMM029728C126">Li et al., 2007</xref>), Dp1Tyb (<xref ref-type="bibr" rid="DMM029728C122">Lana-Elola et al., 2016</xref>) and Ts1Cje (<xref ref-type="bibr" rid="DMM029728C84">Guedj et al., 2016</xref>) embryos. Detailed investigation with several trisomic models refined a critical interval between <italic>Ifnar1</italic> and <italic>KcnJ6</italic> (<xref ref-type="fig" rid="DMM029728F1">Fig. 1</xref>) (<xref ref-type="bibr" rid="DMM029728C180">Raveau et al., 2012</xref>; <xref ref-type="bibr" rid="DMM029728C129">Liu et al., 2011</xref>) and a role for the most distal part of Mmu16 from <italic>mir802</italic> to <italic>Zbtb21</italic> (<xref ref-type="bibr" rid="DMM029728C122">Lana-Elola et al., 2016</xref>). In addition, overexpression of <italic>Jam2</italic>, a gene located upstream of <italic>App</italic> that encodes junctional adhesion molecule 2 found in the tight junctions of endothelial cells, modifies the activity of the matricellular protein cysteine-rich with EGF-like domain protein 1 (CRELD1), leading to enhanced septal defects in Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C127">Li et al., 2016</xref>). Reducing the dosage of another key gene for heart development located outside of Hsa21 homologous regions, T-box transcription factor <italic>Tbx5</italic> worsens CHDs in the Ts65Dn mouse model, evidenced by increasing aortic and atrial-ventricular septal defects (<xref ref-type="bibr" rid="DMM029728C171">Polk et al., 2015</xref>). These studies indicate that several Hsa21 homologous regions contribute to CHDs in DS and that additional genes involved in normal heart development can modify the severity of the heart phenotypes observed in DS models.</p>
<p>Additional DS-related features, such as craniofacial changes, have been described in mouse models, and certain trisomic genes or regions have been implicated in these phenotypes (<xref ref-type="bibr" rid="DMM029728C219">Starbuck et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C187">Richtsmeier et al., 2002</xref>, <xref ref-type="bibr" rid="DMM029728C186">2000</xref>). A mouse-based study has also shed light on hypotonia, a major phenotype observed in DS newborns (<xref ref-type="bibr" rid="DMM029728C232">Vicari, 2006</xref>). Analysis of a mouse model carrying three copies of the <italic>Hspa13-App</italic> region (<xref ref-type="fig" rid="DMM029728F1">Fig. 1</xref>) shows changes in locomotor activity and in muscle strength and physiology, suggesting the contribution of muscular deficits in the periphery (<xref ref-type="bibr" rid="DMM029728C32">Brault et al., 2015a</xref>).</p>
<p>This summary is not exhaustive and many additional DS features have been explored using mouse models, such as the mineralisation of long bones (<xref ref-type="bibr" rid="DMM029728C26">Blazek et al., 2015</xref>), the risk of chronic otitis media (<xref ref-type="bibr" rid="DMM029728C22">Bhutta et al., 2013</xref>), and the higher risk of developing myeloproliferative disorders and cancer (<xref ref-type="bibr" rid="DMM029728C157">Ng et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C221">Sussan et al., 2008</xref>; <xref ref-type="bibr" rid="DMM029728C138">Malinge et al., 2012</xref>; <xref ref-type="bibr" rid="DMM029728C4">Alford et al., 2010</xref>; <xref ref-type="bibr" rid="DMM029728C242">Yang et al., 2016</xref>). Each mouse strain has the potential to provide unique information, and a range of animals, aneuploid and partially trisomic, are important to pinpoint specific candidate genes and dissect the underlying molecular mechanisms.</p>
</sec>
<sec id="s4">
<title>Identification of molecular mechanisms and candidate genes for DS cognitive features</title>
<p>The analysis of DS mouse models has facilitated the identification of specific Hsa21 genes involved in DS features. Initially, DS candidate genes were pinpointed by human genetic analyses or by parallel knowledge of gene function (<xref ref-type="bibr" rid="DMM029728C8">Antonarakis, 2016</xref>; <xref ref-type="bibr" rid="DMM029728C9">Antonarakis et al., 2004</xref>). Two basic experimental approaches in mice have been applied either to increase or decrease the expression of a candidate gene. As described above, a 33-gene region has been identified as being crucial for cognitive impairment in DS, based on a number of mouse behavioural studies (<xref ref-type="bibr" rid="DMM029728C18">Belichenko et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C162">Olson et al., 2007</xref>). Among the genes from this region, <italic>Dyrk1a</italic> was an attractive candidate for inducing cognitive-impairment phenotypes.</p>
<p>Large genomic fragments such as yeast artificial chromosomes (YACs) containing mouse DNA of the locus (<xref ref-type="bibr" rid="DMM029728C209">Smith and Rubin, 1997</xref>; <xref ref-type="bibr" rid="DMM029728C210">Smith et al., 1995</xref>) or bacterial artificial chromosome (BAC) constructs covering the human (<xref ref-type="bibr" rid="DMM029728C3">Ahn et al., 2006</xref>) or the mouse (<xref ref-type="bibr" rid="DMM029728C83">Guedj et al., 2012</xref>) gene, were developed in order to express <italic>Dyrk1a</italic> with a pattern of expression similar to the endogenous gene. The YAC transgenic mouse was used to demonstrate the role of <italic>Dyrk1a</italic> in DS cognitive impairment (<xref ref-type="bibr" rid="DMM029728C205">Sebrié et al., 2008</xref>; <xref ref-type="bibr" rid="DMM029728C175">Rachidi et al., 2007</xref>; <xref ref-type="bibr" rid="DMM029728C191">Roubertoux et al., 2006</xref>; <xref ref-type="bibr" rid="DMM029728C27">Branchi et al., 2004</xref>). The evidence for this was reinforced by applying transgenic approaches to overexpress <italic>Dyrk1a</italic> alone in mice either by using expression vectors driven by an exogenous promoter (<xref ref-type="bibr" rid="DMM029728C5">Altafaj et al., 2001</xref>, <xref ref-type="bibr" rid="DMM029728C6">2013</xref>; <xref ref-type="bibr" rid="DMM029728C78">Grau et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C141">Martinez de Lagrán et al., 2004</xref>) or by using BAC encoding human or mouse <italic>DYRK1A</italic> (<xref ref-type="bibr" rid="DMM029728C3">Ahn et al., 2006</xref>; <xref ref-type="bibr" rid="DMM029728C83">Guedj et al., 2012</xref>). All lines played an important role in understanding the molecular consequences induced by <italic>DYRK1A</italic> overdosage and provided important support for demonstrating molecular alterations in synaptic plasticity pathways, particularly expression changes in GABAergic- and glutamatergic-related proteins (<xref ref-type="bibr" rid="DMM029728C3">Ahn et al., 2006</xref>; <xref ref-type="bibr" rid="DMM029728C166">Park et al., 2012</xref>, <xref ref-type="bibr" rid="DMM029728C165">2010</xref>; <xref ref-type="bibr" rid="DMM029728C212">Song et al., 2015</xref>, <xref ref-type="bibr" rid="DMM029728C211">2013</xref>; <xref ref-type="bibr" rid="DMM029728C214">Souchet et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C174">Rachdi et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C121">Laguna et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C83">Guedj et al., 2012</xref>; <xref ref-type="bibr" rid="DMM029728C213">Souchet et al., 2014</xref>). Similar alterations were observed in models with partial trisomy of Mmu16, Ts65Dn and Dp(16)1Yey, and were reversed in the <italic>Dyrk1a</italic><sup>+/−</sup> model (<xref ref-type="bibr" rid="DMM029728C213">Souchet et al., 2014</xref>). Overexpression of <italic>Dyrk1a</italic> also decreased firing rate and γ-frequency power in the prefrontal network of anesthetised and awake mice, indicating that excess levels of this gene reinforce neuronal inhibition (<xref ref-type="bibr" rid="DMM029728C198">Ruiz-Mejias et al., 2016</xref>).</p>
<p>Reducing the <italic>Dyrk1a</italic> dosage in Ts65Dn mice by crossing Ts65Dn females with heterozygous <italic>Dyrk1a<sup>+/−</sup></italic> male mice revealed that normalization of the <italic>Dyrk1a</italic> copy number improves spatial working, reference memory and contextual conditioning, as well as rescuing hippocampal LTP (<xref ref-type="bibr" rid="DMM029728C71">García-Cerro et al., 2014</xref>). Similar results were obtained by crossing Dp1Yey mice with <italic>Dyrk1a</italic>-knockout mice: rescued trisomic mice with only two functional copies of <italic>Dyrk1a</italic> showed a better performance in the T-maze and FC assays (<xref ref-type="bibr" rid="DMM029728C105">Jiang et al., 2015</xref>). Concomitant with these functional improvements, normalisation of the <italic>Dyrk1a</italic> expression level in trisomic mice restored the proliferation and differentiation of hippocampal cells in the adult dentate gyrus (DG), and the density of GABAergic- and glutamatergic-synapse markers in the molecular layer of the hippocampus (<xref ref-type="bibr" rid="DMM029728C71">García-Cerro et al., 2014</xref>).</p>
<p>Additional genes have been implicated in DS phenotypes in mice. <italic>App</italic> triplication was shown to impact BFCN degeneration, consistent with a role for this AD-associated gene in DS impaired cognition (<xref ref-type="bibr" rid="DMM029728C201">Salehi et al., 2006</xref>). Regulator of calcineurin 1 (Rcan1) inhibits the calcineurin-dependent signalling pathway and its aggregation is controlled by Dyrk1a phosphorylation (<xref ref-type="bibr" rid="DMM029728C211">Song et al., 2013</xref>). Increasing <italic>RCAN1</italic> gene dosage impairs hippocampal LTP (<xref ref-type="bibr" rid="DMM029728C240">Xing et al., 2013</xref>), whereas genetic rescue experiments restore sympathetic nervous system development in Dp1Yey mice (<xref ref-type="bibr" rid="DMM029728C168">Patel et al., 2015</xref>). The gene encoding calmodulin regulator protein Purkinje cell protein 4 (<italic>Pcp4</italic>) has been overexpressed using a P1-phage vector (PAC) to generate transgenic mice that display cerebellar defects (<xref ref-type="bibr" rid="DMM029728C154">Mouton-Liger et al., 2014</xref>, <xref ref-type="bibr" rid="DMM029728C153">2011</xref>). Recently, overexpression of this gene was implicated in the brain ventriculomegaly (<xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>) observed in Ts1Cje mice and in DS-affected humans, and it is thought that the mechanism involves impaired cilia function in ependymal cells, which form the lining of the brain ventricular system (<xref ref-type="bibr" rid="DMM029728C181">Raveau et al., 2017</xref>). Another gene that has been linked to DS is <italic>Kcnj6</italic>, which encodes potassium-voltage-gated channel subfamily J member 6. This gene has been shown to contribute to CHDs (<xref ref-type="bibr" rid="DMM029728C128">Lignon et al., 2008</xref>) and to cognitive defects, together with another gene not yet identified (<xref ref-type="bibr" rid="DMM029728C105">Jiang et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C107">Joshi et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C44">Cooper et al., 2012</xref>). The gene encoding cystathionine β-synthase (<italic>Cbs</italic>), which is involved in the methionine/cysteine cycle, is overexpressed in the DS brain (<xref ref-type="bibr" rid="DMM029728C100">Ichinohe et al., 2005</xref>). Comparable overexpression of <italic>Cbs</italic> using a PAC transgenic line leads to changes in behaviour and LTP in mouse (<xref ref-type="bibr" rid="DMM029728C183">Régnier et al., 2012</xref>), with similar phenotypes being observed in trisomic mice involving larger segments that include <italic>Cbs</italic> (<xref ref-type="bibr" rid="DMM029728C135">Lopes Pereira et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C246">Yu et al., 2010c</xref>).</p>
<p>Several pathways that are perturbed in DS mouse models have been brought to light using transcriptomic and proteomic approaches. A meta-analysis of DS data, selected from human and mouse studies, unveiled perturbed neurological processes involved in neurodegeneration, axon guidance and nerve growth factor (NGF) signalling (<xref ref-type="bibr" rid="DMM029728C234">Vilardell et al., 2011</xref>). A few Hsa21 genes (<italic>SOD1</italic>, <italic>APP</italic>, <italic>DONSON</italic>, <italic>TIAM1</italic>, <italic>COL6A2</italic>, <italic>ITSN1</italic> and <italic>BACE2</italic>) and the brain-derived neurotropic factor (BDNF)-dependent pathway, involved in growth, differentiation and survival of neurons, were found to be altered. An elevated level of BDNF and of Akt-mTOR/Ras-ERK signalling was observed in the hippocampus of Ts1Cje mice, and normal mTOR activity could be restored by treatment with the mTOR inhibitor rapamycin (<xref ref-type="bibr" rid="DMM029728C229">Troca-Marín et al., 2014</xref>, <xref ref-type="bibr" rid="DMM029728C228">2011</xref>). In agreement, <xref ref-type="bibr" rid="DMM029728C1">Ahmed et al. (2013)</xref> also showed that mTOR signalling is deregulated in Tc1 mouse brains.</p>
<p>There are likely to be multiple signalling pathways affected in the DS brain, however. In a recent systems biology study, the transcriptomes of cells taken from DS-affected human fetuses (and unaffected controls) were compared to transcriptome data from the embryonic forebrains of three mouse models (Dp1Yey, Ts65Dn and Ts1Cje) (<xref ref-type="bibr" rid="DMM029728C84">Guedj et al., 2016</xref>). Their analyses revealed that a large panel of cellular processes (cellular stress response, DNA-repair signalling, regulation of cell cycle checkpoints, kinetochore organisation, proteolytic activity and anti-apoptotic genes) and molecular pathways (neurogenesis and neuronal differentiation, mitochondrial function, oxidative stress response, and inflammation) is dysregulated in DS mouse models and humans, indicating that the disease mechanisms are likely to be similar in both species. Another study, involving multi-regional transcriptome analysis of human DS and euploid foetal brains, pointed to misregulation of genes involved in the differentiation of oligodendrocytes and in myelination (<xref ref-type="bibr" rid="DMM029728C159">Olmos-Serrano et al., 2016a</xref>). These findings were confirmed by analysis of Ts65Dn trisomy mice in the same study, highlighting that defects in white matter function could play a part in DS physiopathology. Lastly, epigenetic profiling has revealed multiple loci with altered CpG methylation in human DS and in mouse models, and this phenomenon may reflect increased dosage of Hsa21-linked methylation-pathway genes, such as <italic>DNMT3L</italic>, <italic>SLC19A1</italic> and others, as well as overexpression of key Hsa21-linked transcription factors, such as RUNX1, which could affect epigenetic patterns where they bind DNA (reviewed in <xref ref-type="bibr" rid="DMM029728C62">Do et al., 2017</xref>). Collectively, these studies give an idea of the complexity of DS and emphasise the need to use an integrative approach that includes human samples and animal models, analysed at different periods in development (for example, foetal, early postnatal, young and late adult stages), to better understand the sequence of altered cellular processes and affected pathways in this disease.</p>
</sec>
<sec id="s5">
<title>Therapeutic proof-of-concept for DS</title>
<p>In the last 10 years, a number of studies have sought to assess the efficacy of candidate therapeutic interventions for DS using mouse models. A summary of studies that have explored strategies for rectifying molecular, cellular or systemic defects in DS using mice is given in <xref ref-type="table" rid="DMM029728TB2">Table 2</xref>.
<table-wrap id="DMM029728TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p><bold>Candidate therapeutic approaches for DS</bold></p></caption><graphic xlink:href="dmm-10-029728-i2"></graphic></table-wrap></p>
<p>Some studies have attempted to target defects in neurogenesis and brain development in DS mouse models. The origin of the granule cell deficit in Ts65Dn has been traced to precursors in early postnatal development, which show a substantially reduced mitogenic response to hedgehog protein signaling (<xref ref-type="bibr" rid="DMM029728C190">Roper et al., 2006</xref>; <xref ref-type="bibr" rid="DMM029728C14">Baxter et al., 2000</xref>), a crucial pathway in development. Activation of the sonic hedgehog (SHH) pathway can be achieved by intraperitoneal injection of smoothened agonist (SAG) at postnatal day 2 (P2). Treated Ts65Dn pups have partially corrected cerebellar neurogenesis and hippocampal LTP defects, resulting in improved spatial memory (<xref ref-type="bibr" rid="DMM029728C51">Das et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C87">Gutierrez-Castellanos et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C190">Roper et al., 2006</xref>). However, SAG treatment failed to restore normal cerebellar long-term depression and working memory. Moreover, a key limitation of systemic targeting of the SHH pathways is the potential for such treatment to increase the risk of several types of human cancer (<xref ref-type="bibr" rid="DMM029728C222">Taipale and Beachy, 2001</xref>; <xref ref-type="bibr" rid="DMM029728C104">Jiang and Hui, 2008</xref>). An alternative strategy has been proposed based on use of a γ-secretase inhibitor to reduce overexpression of the SHH receptor PATCHED1 (PTCH1), which represses the SHH pathway. Overexpression of PTCH1 has been reported in Ts65Dn neural precursor cells (NPCs) (<xref ref-type="bibr" rid="DMM029728C227">Trazzi et al., 2013</xref>, <xref ref-type="bibr" rid="DMM029728C226">2011</xref>) and is thought to result from the over-accumulation of the amyloid precursor protein intracellular domain (AICD), which is produced by cleavage of the APP precursor. The increase in AICD leads to overexpression of <italic>PTCH1</italic> in trisomic NPCs, impairing neurogenesis and neurite development (<xref ref-type="bibr" rid="DMM029728C227">Trazzi et al., 2013</xref>, <xref ref-type="bibr" rid="DMM029728C226">2011</xref>). Using an inhibitor of APP γ-secretase, <xref ref-type="bibr" rid="DMM029728C73">Giacomini et al. (2015)</xref> restored neuronal differentiation of Ts65Dn-derived NPCs and, with postnatal treatment, restored neurogenesis in the DG and the subventricular zone of Ts65Dn mice, while also normalising processing of APP. Thus, indirect targeting of the SHH pathway could form the basis of new therapeutic strategies to restore neurogenesis in trisomic brains.</p>
<p>An alternative is stem-cell-based therapy, a promising strategy for many diseases, including DS. Several studies have attempted to implant euploid neural stem cells into the brains of Ts65Dn mice and there is growing evidence that injected cells migrate to sites of damage where they provide neuroprotection. When NSCs were implanted in 12-month-old Ts65Dn mice, extrasomatic granules positive for expression of TAU and REELIN, associated with neuronal ageing, were reduced (<xref ref-type="bibr" rid="DMM029728C110">Kern et al., 2011</xref>). When injected earlier, at P2, these cells induced a significant increase in the density of dentate granule cells and had a long-lasting positive effect on cognitive performance (learning) (<xref ref-type="bibr" rid="DMM029728C176">Rachubinski et al., 2012a</xref>,<xref ref-type="bibr" rid="DMM029728C177">b</xref>). Nevertheless, the stem-cell-based strategy has three limiting factors: (1) cells need to be injected directly into the brain for maximum efficacy; (2) the short-term effect is limited to the injection site and close vicinity; and (3) benefits are transitory and, when they persist, effects are probably linked to NSC-dependent neurotrophin production (<xref ref-type="bibr" rid="DMM029728C177">Rachubinski et al., 2012b</xref>).</p>
<p>Among the other strategies that have been tested in DS mouse models is long-term peripheral administration of peptide 6 – an 11-mer corresponding to an active region of ciliary neurotrophic factor – which can enhance the pool of neural progenitor cells, and ameliorate learning and memory impairments in Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C25">Blanchard et al., 2011</xref>). Three months of treatment with P7C3, an aminopropyl carbazole that enhances hippocampal neurogenesis, is sufficient to restore the neurogenic deficits observed in the Ts65Dn model (<xref ref-type="bibr" rid="DMM029728C123">Latchney et al., 2015</xref>). Prenatal treatment with epigallocatechine gallate (EGCG), an inhibitor of DYRK1A, normalised some craniofacial phenotypes, including the increased cranial vault, in Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C144">McElyea et al., 2016</xref>). Different protocols have demonstrated a beneficial impact of environmental enrichment – a widely used paradigm that increases sensory-motor stimulation – on learning, memory and motor activity in Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C131">Llorens-Martín et al., 2010</xref>; <xref ref-type="bibr" rid="DMM029728C112">Kida et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C17">Begenisic et al., 2015</xref>). The underlying molecular mechanisms responsible for this rescue are poorly understood, although it is thought that increased neurogenesis and synaptogenesis might be involved.</p>
<p>As highlighted above, the mTOR pathway has been implicated in DS. Treatment with the specific mTOR inhibitor rapamycin improved the spatial-memory performance of Ts1Cje mice and restored BDNF-dependent LTP in hippocampal slices (<xref ref-type="bibr" rid="DMM029728C7">Andrade-Talavera et al., 2015</xref>). The same authors showed that deficits in synaptic plasticity (i.e. BDNF-LTP) and in the persistence of spatial memory were fully reversed using rapamycin in the Ts65Dn model (<xref ref-type="bibr" rid="DMM029728C7">Andrade-Talavera et al., 2015</xref>), indicating that targeting mTOR hyperactivation may be a novel pharmacotherapeutical approach for DS. Consistent with this, administration of α-Tocopherol (vitamin E), also known to act upon the mTOR pathway, led to attenuation of cognitive impairments in the Ts65Dn model (<xref ref-type="bibr" rid="DMM029728C133">Lockrow et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C207">Shichiri et al., 2011</xref>).</p>
<p>Different neurotransmission pathways have been shown to be altered in mouse models of DS, and these pathways have been targeted in attempts to improve cognition. In one example, Ts65Dn mice were treated with JZL 184, a selective inhibitor of monoacylglycerol lipase. The lipase degrades the most abundant endocannabinoid and its inactivation improves synaptic plasticity and memory in mouse (<xref ref-type="bibr" rid="DMM029728C164">Pan et al., 2011</xref>). Thus, hippocampal LTP, long-term memory and locomotor activity were restored to a normal level in JZL-184-treated Ts65Dn mice; however, positive thigmotaxis (<xref ref-type="boxed-text" rid="DMM029728B1">Box 1</xref>) and short-term memory defects remained unchanged (<xref ref-type="bibr" rid="DMM029728C137">Lysenko et al., 2014</xref>).</p>
<p>Ts65Dn mice show perturbations of the excitatory/inhibitory balance towards an excess of GABA transmission; this imbalance may also explain cognitive dysfunction in human DS. The ability of antagonists of GABA receptors [including pentylenetetrazol (PTZ), RO4938581 and CGP55845] to normalise this balance has been tested in mouse models. These compounds rescued long-term and spatial memory, hippocampal LTP and the expression of several key molecular markers, including BDNF, GAD65/67 and VGAT (<xref ref-type="bibr" rid="DMM029728C69">Fernandez et al., 2007</xref>; <xref ref-type="bibr" rid="DMM029728C194">Rueda et al., 2008a</xref>; <xref ref-type="bibr" rid="DMM029728C28">Braudeau et al., 2011a</xref>,<xref ref-type="bibr" rid="DMM029728C29">b</xref>; <xref ref-type="bibr" rid="DMM029728C42">Colas et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C233">Vidal et al., 2012</xref>; <xref ref-type="bibr" rid="DMM029728C113">Kleschevnikov et al., 2004</xref>, <xref ref-type="bibr" rid="DMM029728C115">2012b</xref>; <xref ref-type="bibr" rid="DMM029728C140">Martinez-Cue et al., 2013</xref>; <xref ref-type="bibr" rid="DMM029728C47">Costa and Grybko, 2005</xref>). Similarly, the N-methyl-D-aspartate receptor antagonists memantine and MK-801 successfully rescued learning and improved memory, partly by normalising the levels of APP, vGlut1 and BDNF (<xref ref-type="bibr" rid="DMM029728C48">Costa et al., 2008</xref>; <xref ref-type="bibr" rid="DMM029728C2">Ahmed et al., 2015</xref>; <xref ref-type="bibr" rid="DMM029728C196">Rueda et al., 2010</xref>; <xref ref-type="bibr" rid="DMM029728C134">Lockrow et al., 2011</xref>; <xref ref-type="bibr" rid="DMM029728C91">Hanson et al., 2013</xref>). A memantine clinical study is currently underway to assess the effects of this treatment on adolescents with DS (<uri xlink:href="https://www.clinicaltrials.gov/">https://www.clinicaltrials.gov/</uri>).</p>
<p>Prenatal or early postnatal treatment with fluoxetine, which targets the serotoninergic system, rescued neurogenesis, long-term memory and synaptic plasticity in Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C85">Guidi et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C216">Stagni et al., 2015</xref>). Adult treatment enhanced neurogenesis without improving learning/memory deficits at a high dose of fluoxetine (<xref ref-type="bibr" rid="DMM029728C93">Heinen et al., 2012</xref>); however, an improvement in short-term memory was observed using a low dose (<xref ref-type="bibr" rid="DMM029728C16">Begenisic et al., 2014</xref>). As seen with fluoxetine treatment, early administration of lithium, another antidepressant drug acting also upon the serotonin pathway, fully rescued short- and long-term memory, and LTP as well as neurogenesis in Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C43">Contestabile et al., 2013</xref>).</p>
<p>Therapeutic targeting of key candidate genes implicated in DS has also been attempted. Partial display of DS phenotypes in mice harbouring a single trisomy of <italic>Kcnj6</italic> provides compelling evidence for a functional role of increased channel expression in some of the abnormal neurological phenotypes found in DS. However, treatment of Ts65Dn mice with ethosuximide (ETH), an inhibitor of KCNJ6, failed to rescue impairments of motor coordination or cognitive performance (MWM or FC) (<xref ref-type="bibr" rid="DMM029728C233">Vidal et al., 2012</xref>). Given its putative role in DS, researchers have also explored the potential of <italic>DYRK1A</italic> as a therapeutic target. Studies involving inhibition of DYRK1A enzymatic activity using a safe and naturally available inhibitor (EGCG) demonstrated that learning/memory phenotypes could be rescued in different models, including in Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C239">Xie et al., 2008</xref>; <xref ref-type="bibr" rid="DMM029728C82">Guedj et al., 2009</xref>; <xref ref-type="bibr" rid="DMM029728C54">De la Torre et al., 2014</xref>; <xref ref-type="bibr" rid="DMM029728C224">Thomazeau et al., 2014</xref>), despite the fact that other genes are trisomic in this model.</p>
<p>As mentioned above, individuals with DS are at increased risk of developing AD during ageing, and the presence of three copies of APP is known to contribute to this phenomena. Thus, several therapies targeting the APP pathways have been tested. For example, the γ-secretase inhibitor DAPT was shown to improve memory and prevented neurodegeneration in Ts65Dn mice (<xref ref-type="bibr" rid="DMM029728C156">Netzer et al., 2010</xref>). Anti-Aβ vaccine failed to rescue a normal level of Aβ40 and 42 but improved spatial learning of trisomic mice (<xref ref-type="bibr" rid="DMM029728C20">Belichenko et al., 2016</xref>), suggesting that there is no direct relationship between the levels of Aβ and defects in spatial learning. In wild-type rodents, supplementing the maternal diet with additional choline (∼4.5× the amount in normal chow) enhances spatial memory and attention in the offspring, and exerts structural and functional changes in the septo-hippocampal cholinergic system (<xref ref-type="bibr" rid="DMM029728C143">McCann et al., 2006</xref>): these results suggested that maternal choline supplementation (MCS) could enhance cognitive function and protect against BFCN degeneration. MCS given to Ts65Dn mice significantly improved spatial mapping and increased the number, density and size of medial septum BFCNs (<xref ref-type="bibr" rid="DMM029728C146">Moon et al., 2010</xref>; <xref ref-type="bibr" rid="DMM029728C12">Ash et al., 2014</xref>). MCS also seems to protect against hippocampal cholinergic projection system degeneration (<xref ref-type="bibr" rid="DMM029728C109">Kelley et al., 2016</xref>).</p>
<p>Long-term exposure to environmental enrichment reduces Aβ oligomers and rescues spatial-memory abilities in 12-month-old trisomic mice (<xref ref-type="bibr" rid="DMM029728C204">Sansevero et al., 2016</xref>). Estrogen treatment partially rescued working memory (T-maze test) and prevented neurodegeneration in aged Ts65Dn animals (11- to 17-months old) (<xref ref-type="bibr" rid="DMM029728C76">Granholm et al., 2002</xref>, <xref ref-type="bibr" rid="DMM029728C77">2003</xref>). Consistent with a role for inflammatory processes in BFCN degeneration, minocycline treatment inhibits microglial activation, prevents progressive BFCN decline and markedly improves performance of Ts65Dn mice on a working and reference memory task (<xref ref-type="bibr" rid="DMM029728C98">Hunter et al., 2004a</xref>). Partially reducing β-secretase 1 (BACE1) by deleting one <italic>BACE1</italic> allele blocked development of age-related endosome enlargement in the medial septal nucleus, cerebral cortex and hippocampus, and prevented loss of choline acetyltransferase (ChAT)-positive medial septal nucleus neurons (<xref ref-type="bibr" rid="DMM029728C106">Jiang et al., 2016</xref>).</p>
<p>These potential therapeutic approaches have been tested ‘preclinically’ in DS mouse models (mostly in Ts65Dn mice) across different laboratories. Many different compounds and manipulations have produced beneficial effects. However, apart from EGCG and GABA-targeting compounds, the efficacy of specific strategies have not been validated in an independent study. Testing for interlaboratory reproducibility of the results, and reproducibility in more than one mouse model, will be crucial next steps in this exciting research area.</p>
</sec>
<sec id="s6">
<title>Future directions for DS research</title>
<p>As highlighted here, DS mouse models are providing important insight into this complex disorder. Chromosome engineering technologies now enable us to address more refined questions, including, for example, on synergy and epistatic interaction between Hsa21 genes. The panel of new technologies provides the opportunity to broaden the range of animal models to include the rat or primates, although it must be emphasised that such models should only be developed where justified by the scientific question and there is clear added value compared to available models. A key limitation of DS mouse models is that most of the phenotypes have been described in a few genetic backgrounds, mostly pure inbred C57BL/6J mice, and for a few lines only in the F1, potentially reducing complex genetic interactions and their influence on the penetrance and expressivity of the phenotypes. It is widely known that the genetic background can impact on phenotypic outcome in mice; for example, in some backgrounds, homozygous knockout of epidermal growth factor receptor (EGFR) is lethal, whereas, in other backgrounds, the mutant is viable (<xref ref-type="bibr" rid="DMM029728C225">Threadgill et al., 1995</xref>; <xref ref-type="bibr" rid="DMM029728C203">Sanford et al., 2001</xref>). An impact on phenotype is also observed when modelling intellectual disabilities, autism spectrum disorders or psychiatric diseases (<xref ref-type="bibr" rid="DMM029728C208">Sittig et al., 2016</xref>; <xref ref-type="bibr" rid="DMM029728C11">Arbogast et al., 2016</xref>). Thus, addressing the interindividual phenotypic variability in DS will require strategies either to develop models in various genetic mixed backgrounds, e.g. with the F1 modelling approach proposed by <xref ref-type="bibr" rid="DMM029728C208">Sittig et al. (2016)</xref>, or to bring new genetic diversity using, for example, the Collaborative Cross lines (<uri xlink:href="http://csbio.unc.edu/CCstatus/index.py">http://csbio.unc.edu/CCstatus/index.py</uri>) or using large cohorts derived in an outbred genetic background. In parallel, the use of large cohorts of ethnically and genetically diverse DS individuals will help to capture the variability in the human population.</p>
<p>The complex nature of DS creates the need for collaborative, multidiscliplinary research to understand its biology. One key step was the formation of the T21 Research Society (T21RS), a global initiative that provides freely available, curated and therefore up-to-date web resources, including validated models and protocols for behavioural and pharmacological treatment. The T21RS society is unique and aims to develop and coordinate action to generate new models to make them available and to propose standard operating protocols for behavioural investigation of DS. Moreover, mouse-based research into DS has resulted in the advancement of a few different treatments to human clinical trials. Promising results have been obtained in terms of improvement of cognitive function and the autonomy of individuals with DS (<xref ref-type="bibr" rid="DMM029728C55">de la Torre et al., 2016</xref>, <xref ref-type="bibr" rid="DMM029728C54">2014</xref>), but more work is needed to better assess drug efficacy, the consequence of long-term treatment and the impact of treatment timing. In addition, most of the treatments were evaluated in a Ts65Dn mouse model, which only recapitulates the trisomy partially, lacking about half of the mouse genes that are homologous to those on Hsa21. The use of more complex mouse models, such as Dp1Yey and Dp1Tyb or those that combine trisomies for Mmu16, Mmu17 and Mmu10 homologous regions (<xref ref-type="bibr" rid="DMM029728C245">Yu et al., 2010b</xref>), should be developed for reliable therapeutic assessment.</p>
<p>Models developed in other species, such as rat, are likely to be helpful to validate genotype-phenotype relationships and the outcome of preclinical treatments. Furthermore, we may have access to new avenues for therapeutic intervention. Firstly, we could adapt a treatment to the age of DS individuals, so aiming to counteract neurodevelopmental defects as early as possible, and decreasing the risk of comorbidities in the adult and during ageing. Before devising strategies for prenatal treatment, it is important to understand in depth the development of disomic versus trisomic human foetuses. New tools will also certainly contribute to new strategies. Notably, the use of CRISPR/Cas9 or CRISMERE tools could lead to therapeutic strategies for reducing the overdosage of a given gene or a genomic region in trisomic individuals by inactivating one of the three alleles, for example, in transplantable stem cells or induced pluripotent stem cells. Finally, DS models will continue to be improved in the next few years. As noted above, most drug candidates to date have been tested in the Ts65Dn model, which carries only ∼90 of the Hsa21 homologous genes and includes ∼60 additional genes that are not orthologous to Hsa21. Thus, we must consider more complete models to evaluate therapeutic options even though these may be difficult to breed at present (<xref ref-type="bibr" rid="DMM029728C19">Belichenko et al., 2015</xref>). An intriguing alternative is provided by the transchromosomic strategy that brings a complete set of Hsa21 genes into the mouse genome. However, this approach has some pitfalls: (1) human proteins or non-coding RNAs may not be able to interact with the same efficiency and efficacy with their mouse partners; (2) the regulation of human sequences may differ from the mouse genes, leading to unexpected domains of expression; and (3) the human allelic repertoire will be fixed in each strain. Despite the limitations, the progress to date has been promising and there is little doubt that mouse-based DS research will be important for translation into therapies for DS in the future.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank members of the research groups for their helpful suggestions and discussions. Mouse models are available through the Jackson Laboratory or the Infrafrontier infrastructure [European Mutant Mouse Archive (EMMA)].</p>
</ack>
<fn-group>
<title>Footnotes</title>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare no competing or financial interests.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>
<bold>Funding</bold>
</p>
<p>This work has been supported by the National Centre for Scientific Research [Centre National de la Recherche Scientifique (CNRS)], the French National Institute of Health and Medical Research [Institut National de la Santé et de la Recherche Médicale (INSERM)], the University of Strasbourg [Université de Strasbourg (UDS)], the ‘Centre Européen de Recherche en Biologie et en Médecine’, the European Commission (AnEUploidy project to V.L.J.T., E.M.C.F., Y.H. and J.M.D.; Fifth Framework Programme LSHG-CT-2006-037627), the French State funds through the ‘Agence Nationale de la Recherche’ under the frame programme Investissements d'Avenir (ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT, ANR-10-INBS-07 PHENOMIN), from the EU FP7 large-scale integrated project GENCODYS (Sixth Framework Programme grant 241995) to Y.H. and under ANR-09-MNPS-008 to J.M.D. V.L.J.T. and E.M.C.F. were funded by Wellcome Trust grants 080174, 098327 and 098328. V.L.J.T. was also supported by the Francis Crick Institute (FC001194), which receives its core funding from the MRC, Cancer Research UK and the Wellcome Trust. E.Y. was supported in part by grants from the National Institutes of Health (R01NS66072, R01HL91519, R21GM114645 and P30CA16056), The Children's Guild Foundation and Roswell Park Alliance Foundation, Roswell Park Cancer Institute. The Jérôme Lejeune Foundation (Fondation Jérôme Lejeune) supports the work of J.M.D., E.Y., Y.H. and V.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="DMM029728C1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Dhanasekaran</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wiseman</surname><given-names>F. K.</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>E. M. C.</given-names></name>, <name name-style="western"><surname>Tybulewicz</surname><given-names>V. L. J.</given-names></name> and <name name-style="western"><surname>Gardiner</surname><given-names>K. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>, <fpage>1709</fpage>-<lpage>1724</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt017</pub-id><pub-id pub-id-type="pmid">23349361</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Dhanasekaran</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Block</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>A. C. S.</given-names></name>, <name name-style="western"><surname>Stasko</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Gardiner</surname><given-names>K. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Protein dynamics associated with failed and rescued learning in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>10</volume>, <fpage>e0119491</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0119491</pub-id><pub-id pub-id-type="pmid">25793384</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahn</surname><given-names>K.-J.</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>H. K.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>H.-S.</given-names></name>, <name name-style="western"><surname>Ryoo</surname><given-names>S.-R.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>Y. J.</given-names></name>, <name name-style="western"><surname>Goo</surname><given-names>J.-S.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>S.-Y.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>J.-S.</given-names></name>, <name name-style="western"><surname>Ha</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Song</surname><given-names>W.-J.</given-names></name></person-group> (<year>2006</year>). <article-title>DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>22</volume>, <fpage>463</fpage>-<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2005.12.006</pub-id><pub-id pub-id-type="pmid">16455265</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alford</surname><given-names>K. A.</given-names></name>, <name name-style="western"><surname>Slender</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Vanes</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>E. M. C.</given-names></name>, <name name-style="western"><surname>Nizetic</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Orkin</surname><given-names>S. H.</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Tybulewicz</surname><given-names>V. L. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome</article-title>. <source/><italic>Blood</italic>
<volume>115</volume>, <fpage>2928</fpage>-<lpage>2937</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2009-06-227629</pub-id><pub-id pub-id-type="pmid">20154221</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altafaj</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Baamonde</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Marti</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Visa</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Guimera</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Oset</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Florez</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Fillat</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>). <article-title>Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>10</volume>, <fpage>1915</fpage>-<lpage>1923</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/10.18.1915</pub-id><pub-id pub-id-type="pmid">11555628</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altafaj</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Martín</surname><given-names>E. D.</given-names></name>, <name name-style="western"><surname>Ortiz-Abalia</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Valderrama</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lao-Peregrín</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Fillat</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>52</volume>, <fpage>117</fpage>-<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.11.017</pub-id><pub-id pub-id-type="pmid">23220201</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andrade-Talavera</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Benito</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Casañas</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Rodríguez-Moreno</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Montesinos</surname><given-names>M. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Rapamycin restores BDNF-LTP and the persistence of long-term memory in a model of Down's syndrome</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>82</volume>, <fpage>516</fpage>-<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2015.09.005</pub-id><pub-id pub-id-type="pmid">26388397</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antonarakis</surname><given-names>S. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Down syndrome and the complexity of genome dosage imbalance</article-title>. <source/><italic>Nat. Rev. Genet.</italic>
<volume>18</volume>, <fpage>147</fpage>-<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1038/nrg.2016.154</pub-id><pub-id pub-id-type="pmid">28029161</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antonarakis</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Lyle</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Dermitzakis</surname><given-names>E. T.</given-names></name>, <name name-style="western"><surname>Reymond</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Deutsch</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Chromosome 21 and down syndrome: from genomics to pathophysiology</article-title>. <source/><italic>Nat. Rev. Genet.</italic>
<volume>5</volume>, <fpage>725</fpage>-<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1038/nrg1448</pub-id><pub-id pub-id-type="pmid">15510164</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arbogast</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Raveau</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chevalier</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Nalesso</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Dembele</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wendling</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Deletion of the App-Runx1 region in mice models human partial monosomy 21</article-title>. <source/><italic>Dis. Model. Mech.</italic>
<volume>8</volume>, <fpage>623</fpage>-<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.017814</pub-id><pub-id pub-id-type="pmid">26035870</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arbogast</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ouagazzal</surname><given-names>A.-M.</given-names></name>, <name name-style="western"><surname>Chevalier</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kopanitsa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Afinowi</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Migliavacca</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Cowling</surname><given-names>B. S.</given-names></name>, <name name-style="western"><surname>Birling</surname><given-names>M.-C.</given-names></name>, <name name-style="western"><surname>Champy</surname><given-names>M.-F.</given-names></name>, <name name-style="western"><surname>Reymond</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Reciprocal effects on neurocognitive and metabolic phenotypes in mouse models of 16p11.2 deletion and duplication syndromes</article-title>. <source/><italic>PLoS Genet.</italic>
<volume>12</volume>, <fpage>e1005709</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005709</pub-id><pub-id pub-id-type="pmid">26872257</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ash</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Velazquez</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Powers</surname><given-names>B. E.</given-names></name>, <name name-style="western"><surname>Ginsberg</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Mufson</surname><given-names>E. J.</given-names></name> and <name name-style="western"><surname>Strupp</surname><given-names>B. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>70</volume>, <fpage>32</fpage>-<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.06.001</pub-id><pub-id pub-id-type="pmid">24932939</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballard</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mobley</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Hardy</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Corbett</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Dementia in Down's syndrome</article-title>. <source/><italic>Lancet Neurol.</italic>
<volume>15</volume>, <fpage>622</fpage>-<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(16)00063-6</pub-id><pub-id pub-id-type="pmid">27302127</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baxter</surname><given-names>L. L.</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>T. H.</given-names></name>, <name name-style="western"><surname>Richtsmeier</surname><given-names>J. T.</given-names></name>, <name name-style="western"><surname>Troncoso</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>9</volume>, <fpage>195</fpage>-<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.2.195</pub-id><pub-id pub-id-type="pmid">10607830</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beach</surname><given-names>R. R.</given-names></name>, <name name-style="western"><surname>Ricci-Tam</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Brennan</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Moomau</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>P.-H.</given-names></name>, <name name-style="western"><surname>Hua</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Silberman</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Springer</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Amon</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Aneuploidy causes non-genetic individuality</article-title>. <source/><italic>Cell</italic>
<volume>169</volume>, <fpage>229</fpage>-<lpage>242.e21</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.03.021</pub-id><pub-id pub-id-type="pmid">28388408</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Begenisic</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Baroncelli</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sansevero</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Milanese</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bonifacino</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Bonanno</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Cioni</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Maffei</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Sale</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>63</volume>, <fpage>12</fpage>-<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.11.010</pub-id><pub-id pub-id-type="pmid">24269730</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Begenisic</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sansevero</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Baroncelli</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Cioni</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Sale</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Early environmental therapy rescues brain development in a mouse model of Down syndrome</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>82</volume>, <fpage>409</fpage>-<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2015.07.014</pub-id><pub-id pub-id-type="pmid">26244989</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belichenko</surname><given-names>N. P.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Kleschevnikov</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Salehi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name> and <name name-style="western"><surname>Mobley</surname><given-names>W. C.</given-names></name></person-group> (<year>2009</year>). <article-title>The “Down syndrome critical region” is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>29</volume>, <fpage>5938</fpage>-<lpage>5948</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1547-09.2009</pub-id><pub-id pub-id-type="pmid">19420260</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Kleschevnikov</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>G. E.</given-names></name>, <name name-style="western"><surname>Lysenko</surname><given-names>L. V.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y. E.</given-names></name> and <name name-style="western"><surname>Mobley</surname><given-names>W. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Down syndrome cognitive phenotypes modeled in mice trisomic for All HSA 21 homologues</article-title>. <source/><italic>PLoS ONE</italic>
<volume>10</volume>, <fpage>e0134861</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0134861</pub-id><pub-id pub-id-type="pmid">26230397</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Madani</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Rey-Bellet</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Pihlgren</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Plassard</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Vuillermot</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Giriens</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Nosheny</surname><given-names>R. L.</given-names></name>, <name name-style="western"><surname>Kleschevnikov</surname><given-names>A. M.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>An anti-beta-amyloid vaccine for treating cognitive deficits in a mouse model of Down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>11</volume>, <fpage>e0152471</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0152471</pub-id><pub-id pub-id-type="pmid">27023444</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Besson</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Brault</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Togbe</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Bizot</surname><given-names>J.-C.</given-names></name>, <name name-style="western"><surname>Quesniaux</surname><given-names>V. F. J.</given-names></name>, <name name-style="western"><surname>Ryffel</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Modeling the monosomy for the telomeric part of human chromosome 21 reveals haploinsufficient genes modulating the inflammatory and airway responses</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>16</volume>, <fpage>2040</fpage>-<lpage>2052</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm152</pub-id><pub-id pub-id-type="pmid">17591625</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhutta</surname><given-names>M. F.</given-names></name>, <name name-style="western"><surname>Cheeseman</surname><given-names>M. T.</given-names></name>, <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y. E.</given-names></name> and <name name-style="western"><surname>Brown</surname><given-names>S. D. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Surveying the Down syndrome mouse model resource identifies critical regions responsible for chronic otitis media</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>24</volume>, <fpage>439</fpage>-<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-013-9475-x</pub-id><pub-id pub-id-type="pmid">24068166</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bianchi</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Ciani</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Guidi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Trazzi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Felice</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Grossi</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Fernandez</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Giuliani</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Calza</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Bartesaghi</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>30</volume>, <fpage>8769</fpage>-<lpage>8779</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0534-10.2010</pub-id><pub-id pub-id-type="pmid">20592198</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Birling</surname><given-names>M.-C.</given-names></name>, <name name-style="western"><surname>Schaeffer</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>André</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lindner</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Maréchal</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Ayadi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sorg</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Pavlovic</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Efficient and rapid generation of large genomic variants in rats and mice using CRISMERE</article-title>. <source/><italic>Sci. Rep.</italic>
<volume>7</volume>, <fpage>43331</fpage>
<pub-id pub-id-type="doi">10.1038/srep43331</pub-id><pub-id pub-id-type="pmid">28266534</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanchard</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bolognin</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chohan</surname><given-names>M. O.</given-names></name>, <name name-style="western"><surname>Rabe</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Iqbal</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Grundke-Iqbal</surname><given-names>I.</given-names></name></person-group> (<year>2011</year>). <article-title>Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome</article-title>. <source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>70</volume>, <fpage>1070</fpage>-<lpage>1079</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e318236e9ad</pub-id><pub-id pub-id-type="pmid">22082658</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blazek</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Malik</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Tischbein</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Arbones</surname><given-names>M. L.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>C. S.</given-names></name> and <name name-style="western"><surname>Roper</surname><given-names>R. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner</article-title>. <source/><italic>Mech. Dev.</italic>
<volume>136</volume>, <fpage>133</fpage>-<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/j.mod.2014.12.004</pub-id><pub-id pub-id-type="pmid">25556111</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Branchi</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Bichler</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Minghetti</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Delabar</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Malchiodi-Albedi</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>M.-C.</given-names></name>, <name name-style="western"><surname>Chettouh</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Nicolini</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Chabert</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>D. J.</given-names></name><etal>et al.</etal></person-group> (<year>2004</year>). <article-title>Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration</article-title>. <source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>63</volume>, <fpage>429</fpage>-<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/63.5.429</pub-id><pub-id pub-id-type="pmid">15198122</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braudeau</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dauphinot</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Loistron</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dodd</surname><given-names>R. H.</given-names></name>, <name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Delatour</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Potier</surname><given-names>M. C.</given-names></name></person-group> (<year>2011a</year>). <article-title>Chronic treatment with a promnesiant GABA-A alpha5-selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a Down syndrome mouse model</article-title>. <source/><italic>Adv. Pharmacol. Sci.</italic>
<volume>2011</volume>, <fpage>153218</fpage>
<pub-id pub-id-type="doi">10.1155/2011/153218</pub-id><pub-id pub-id-type="pmid">22028705</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braudeau</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Delatour</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>P. L.</given-names></name>, <name name-style="western"><surname>Dauphinot</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>De Chaumont</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Olivo-Marin</surname><given-names>J.-C.</given-names></name>, <name name-style="western"><surname>Dodd</surname><given-names>R. H.</given-names></name>, <name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Potier</surname><given-names>M.-C.</given-names></name></person-group> (<year>2011b</year>). <article-title>Specific targeting of the GABA-A receptor alpha5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice</article-title>. <source/><italic>J. Psychopharmacol.</italic>
<volume>25</volume>, <fpage>1030</fpage>-<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1177/0269881111405366</pub-id><pub-id pub-id-type="pmid">21693554</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brault</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization</article-title>. <source/><italic>PLoS Genet.</italic>
<volume>2</volume>, <fpage>e86</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.0020086</pub-id><pub-id pub-id-type="pmid">16839184</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brault</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Besson</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Magnol</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Cre/loxP-mediated chromosome engineering of the mouse genome</article-title>. <source/><italic>Handb. Exp. Pharmacol.</italic>
<volume>178</volume>, <fpage>29</fpage>-<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-540-35109-2_2</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brault</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Romestaing</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sahun</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Pothion</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Karout</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Borel</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Dembele</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Bizot</surname><given-names>J.-C.</given-names></name>, <name name-style="western"><surname>Messaddeq</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2015a</year>). <article-title>Opposite phenotypes of muscle strength and locomotor function in mouse models of partial trisomy and monosomy 21 for the proximal Hspa13-App region</article-title>. <source/><italic>PLoS Genet.</italic>
<volume>11</volume>, <fpage>e1005062</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005062</pub-id><pub-id pub-id-type="pmid">25803843</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brault</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Romestaing</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sahun</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Karout</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Borel</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Dembele</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Bizot</surname><given-names>J.-C.</given-names></name>, <name name-style="western"><surname>Messaddeq</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Roussell</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2015b</year>). <article-title>Locomotor dysfonction and hypotonia in Down syndrome mouse models for the HSPA13-APP region as a consequence of dosage sensitive genes controlling muscular metabolism and mitochondrial function</article-title>. <source/><italic>Acta Physiol.</italic>
<volume>214</volume>, <fpage>11</fpage>-<lpage>12</lpage>.</mixed-citation>
</ref>
<ref id="DMM029728C34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Canfield</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Honein</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Yuskiv</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mai</surname><given-names>C. T.</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Devine</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Petrini</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ramadhani</surname><given-names>T. A.</given-names></name>, <name name-style="western"><surname>Hobbs</surname><given-names>C. A.</given-names></name><etal>et al.</etal></person-group> (<year>2006</year>). <article-title>National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001</article-title>. <source/><italic>Birth Defects Res. A Clin. Mol. Teratol</italic>
<volume>76</volume>, <fpage>747</fpage>-<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1002/bdra.20294</pub-id><pub-id pub-id-type="pmid">17051527</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cataldo</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Peterhoff</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Troncoso</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Gomez-Isla</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hyman</surname><given-names>B. T.</given-names></name> and <name name-style="western"><surname>Nixon</surname><given-names>R. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations</article-title>. <source/><italic>Am. J. Pathol.</italic>
<volume>157</volume>, <fpage>277</fpage>-<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64538-5</pub-id><pub-id pub-id-type="pmid">10880397</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cataldo</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>P. M.</given-names></name>, <name name-style="western"><surname>Boiteau</surname><given-names>A. B.</given-names></name>, <name name-style="western"><surname>Hassinger</surname><given-names>L. C.</given-names></name>, <name name-style="western"><surname>Peterhoff</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Mullaney</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Neve</surname><given-names>R. L.</given-names></name>, <name name-style="western"><surname>Gruenberg</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Nixon</surname><given-names>R. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects</article-title>. <source/><italic>Am. J. Pathol.</italic>
<volume>173</volume>, <fpage>370</fpage>-<lpage>384</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2008.071053</pub-id><pub-id pub-id-type="pmid">18535180</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>Q.</given-names></name> and <name name-style="western"><surname>Gold</surname><given-names>P. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome</article-title>. <source/><italic>Neurobiol. Learn. Mem.</italic>
<volume>89</volume>, <fpage>167</fpage>-<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2007.05.007</pub-id><pub-id pub-id-type="pmid">17644430</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C.-K.</given-names></name>, <name name-style="western"><surname>Symmons</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Uslu</surname><given-names>V. V.</given-names></name>, <name name-style="western"><surname>Tsujimura</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ruf</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Smedley</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Spitz</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>TRACER: a resource to study the regulatory architecture of the mouse genome</article-title>. <source/><italic>BMC Genomics</italic>
<volume>14</volume>, <fpage>215</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-14-215</pub-id><pub-id pub-id-type="pmid">23547943</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choong</surname><given-names>X. Y.</given-names></name>, <name name-style="western"><surname>Tosh</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Pulford</surname><given-names>L. J.</given-names></name> and <name name-style="western"><surname>Fisher</surname><given-names>E. M. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Dissecting Alzheimer disease in Down syndrome using mouse models</article-title>. <source/><italic>Front. Behav. Neurosci.</italic>
<volume>9</volume>, <fpage>268</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2015.00268</pub-id><pub-id pub-id-type="pmid">26528151</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schwalbe</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Stasko</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Yarowsky</surname><given-names>P. J.</given-names></name> and <name name-style="western"><surname>Costa</surname><given-names>A. C. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome</article-title>. <source/><italic>Exp. Neurol.</italic>
<volume>200</volume>, <fpage>256</fpage>-<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2006.02.005</pub-id><pub-id pub-id-type="pmid">16624293</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>S. J.</given-names></name> and <name name-style="western"><surname>Stackman</surname><given-names>R. W.</given-names><suffix>Jr</suffix></name></person-group> (<year>2015</year>). <article-title>Assessing rodent hippocampal involvement in the novel object recognition task. A review</article-title>. <source/><italic>Behav. Brain Res.</italic>
<volume>285</volume>, <fpage>105</fpage>-<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.08.002</pub-id><pub-id pub-id-type="pmid">25169255</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colas</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Chuluun</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Warrier</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Blank</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wetmore</surname><given-names>D. Z.</given-names></name>, <name name-style="western"><surname>Buckmaster</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Garner</surname><given-names>C. C.</given-names></name> and <name name-style="western"><surname>Heller</surname><given-names>H. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome</article-title>. <source/><italic>Br. J. Pharmacol.</italic>
<volume>169</volume>, <fpage>963</fpage>-<lpage>973</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12169</pub-id><pub-id pub-id-type="pmid">23489250</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Contestabile</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Greco</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Ghezzi</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Tucci</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Benfenati</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Gasparini</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Lithium rescues synaptic plasticity and memory in Down syndrome mice</article-title>. <source/><italic>J. Clin. Invest.</italic>
<volume>123</volume>, <fpage>348</fpage>-<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1172/JCI64650</pub-id><pub-id pub-id-type="pmid">23202733</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Grigoryan</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Guy-David</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Tsoory</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Reuveny</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>109</volume>, <fpage>2642</fpage>-<lpage>2647</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1109099109</pub-id><pub-id pub-id-type="pmid">22308328</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corrales</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Martínez</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>García</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>García</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Flórez</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sanchez-Barceló</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Martínez-Cué</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Rueda</surname><given-names>N.</given-names></name></person-group> (<year>2013</year>). <article-title>Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome</article-title>. <source/><italic>J. Pineal Res.</italic>
<volume>54</volume>, <fpage>346</fpage>-<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1111/jpi.12037</pub-id><pub-id pub-id-type="pmid">23350971</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corrales</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>García</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Martínez</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>García</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Flórez</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sanchez-Barceló</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Martínez-Cué</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Rueda</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome</article-title>. <source/><italic>J. Pineal Res.</italic>
<volume>56</volume>, <fpage>51</fpage>-<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1111/jpi.12097</pub-id><pub-id pub-id-type="pmid">24147912</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>A. C. S.</given-names></name> and <name name-style="western"><surname>Grybko</surname><given-names>M. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome</article-title>. <source/><italic>Neurosci. Lett.</italic>
<volume>382</volume>, <fpage>317</fpage>-<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2005.03.031</pub-id><pub-id pub-id-type="pmid">15925111</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>A. C. S.</given-names></name>, <name name-style="western"><surname>Scott-Mckean</surname><given-names>J. J.</given-names></name> and <name name-style="western"><surname>Stasko</surname><given-names>M. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test</article-title>. <source/><italic>Neuropsychopharmacology</italic>
<volume>33</volume>, <fpage>1624</fpage>-<lpage>1632</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1301535</pub-id><pub-id pub-id-type="pmid">17700645</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dang</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Medina</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Moghadam</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>K. J.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Naik</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Nosheny</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wesson Ashford</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Formoterol, a long-acting beta2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome</article-title>. <source/><italic>Biol. Psychiatry</italic>
<volume>75</volume>, <fpage>179</fpage>-<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.05.024</pub-id><pub-id pub-id-type="pmid">23827853</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Das</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2011</year>). <article-title>The use of mouse models to understand and improve cognitive deficits in Down syndrome</article-title>. <source/><italic>Dis. Model. Mech.</italic>
<volume>4</volume>, <fpage>596</fpage>-<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.007716</pub-id><pub-id pub-id-type="pmid">21816951</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Das</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J.-M.</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Jeon</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Lorenzi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Linden</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Worley</surname><given-names>P. F.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model</article-title>. <source/><italic>Sci. Transl. Med.</italic>
<volume>5</volume>, <fpage>201ra120</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3005983</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davisson</surname><given-names>M. T.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Akeson</surname><given-names>E. C.</given-names></name></person-group> (<year>1990</year>). <article-title>Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome</article-title>. <source/><italic>Prog. Clin. Biol. Res.</italic>
<volume>360</volume>, <fpage>263</fpage>-<lpage>280</lpage>.<pub-id pub-id-type="pmid">2147289</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Graaf</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Buckley</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Skotko</surname><given-names>B. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Live births, natural losses, and elective terminations with Down syndrome in Massachusetts</article-title>. <source/><italic>Genet. Med.</italic>
<volume>18</volume>, <fpage>459</fpage>-<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2016.15</pub-id><pub-id pub-id-type="pmid">27126496</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De la Torre</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>De Sola</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pons</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>De Lagran</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Farré</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fitó</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Benejam</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Langohr</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans</article-title>. <source/><italic>Mol. Nutr. Food Res.</italic>
<volume>58</volume>, <fpage>278</fpage>-<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.201300325</pub-id><pub-id pub-id-type="pmid">24039182</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De la Torre</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>De Sola</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Farré</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pujol</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Espadaler</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Langohr</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Cuenca-Royo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Principe</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial</article-title>. <source/><italic>Lancet Neurol.</italic>
<volume>15</volume>, <fpage>801</fpage>-<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(16)30034-5</pub-id><pub-id pub-id-type="pmid">27302362</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Souza</surname><given-names>F. M. S.</given-names></name>, <name name-style="western"><surname>Busquet</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Blatner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Maclean</surname><given-names>K. N.</given-names></name> and <name name-style="western"><surname>Restrepo</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Sci. Rep.</italic>
<volume>1</volume>, <fpage>137</fpage>
<pub-id pub-id-type="doi">10.1038/srep00137</pub-id><pub-id pub-id-type="pmid">22355654</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dekker</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Strydom</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Coppus</surname><given-names>A. M. W.</given-names></name>, <name name-style="western"><surname>Nizetic</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Vermeiren</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Naudé</surname><given-names>P. J. W.</given-names></name>, <name name-style="western"><surname>Van Dam</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Potier</surname><given-names>M.-C.</given-names></name>, <name name-style="western"><surname>Fortea</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>De Deyn</surname><given-names>P. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?</article-title>
<source/><italic>Cortex</italic>
<volume>73</volume>, <fpage>36</fpage>-<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.cortex.2015.07.032</pub-id><pub-id pub-id-type="pmid">26343344</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delabar</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Theophile</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Rahmani</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Chettouh</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Blouin</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Prieur</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Noel</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Sinet</surname><given-names>P. M.</given-names></name></person-group> (<year>1993</year>). <article-title>Molecular mapping of twenty-four features of Down syndrome on chromosome 21</article-title>. <source/><italic>Eur. J. Hum. Genet.</italic>
<volume>1</volume>, <fpage>114</fpage>-<lpage>124</lpage>.<pub-id pub-id-type="pmid">8055322</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D'hooge</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>De Deyn</surname><given-names>P. P.</given-names></name></person-group> (<year>2001</year>). <article-title>Applications of the Morris water maze in the study of learning and memory</article-title>. <source/><italic>Brain Res. Rev.</italic>
<volume>36</volume>, <fpage>60</fpage>-<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-0173(01)00067-4</pub-id><pub-id pub-id-type="pmid">11516773</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>De Lagrán</surname><given-names>M. M.</given-names></name></person-group> (<year>2006</year>). <article-title>DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A): a gene with dosage effect during development and neurogenesis</article-title>. <source/><italic>ScientificWorldJournal</italic>
<volume>6</volume>, <fpage>1911</fpage>-<lpage>1922</lpage>. <pub-id pub-id-type="doi">10.1100/tsw.2006.319</pub-id><pub-id pub-id-type="pmid">17205196</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Estivill</surname><given-names>X.</given-names></name></person-group> (<year>2009</year>). <article-title>Aneuploidy: from a physiological mechanism of variance to Down syndrome</article-title>. <source/><italic>Physiol. Rev.</italic>
<volume>89</volume>, <fpage>887</fpage>-<lpage>920</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00032.2007</pub-id><pub-id pub-id-type="pmid">19584316</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Do</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y. E.</given-names></name> and <name name-style="western"><surname>Tycko</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models</article-title>. <source/><italic>Epigenomics</italic>
<volume>9</volume>, <fpage>189</fpage>-<lpage>207</lpage>. <pub-id pub-id-type="doi">10.2217/epi-2016-0138</pub-id><pub-id pub-id-type="pmid">27911079</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowjat</surname><given-names>W. K.</given-names></name>, <name name-style="western"><surname>Adayev</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kuchna</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Nowicki</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Palminiello</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>Y. W.</given-names></name> and <name name-style="western"><surname>Wegiel</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome</article-title>. <source/><italic>Neurosci. Lett.</italic>
<volume>413</volume>, <fpage>77</fpage>-<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2006.11.026</pub-id><pub-id pub-id-type="pmid">17145134</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>DYRK1a, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in Down syndrome</article-title>. <source/><italic>Front. Behav. Neurosci.</italic>
<volume>10</volume>, <fpage>104</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2016.00104</pub-id><pub-id pub-id-type="pmid">27375444</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Besson</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>P. L.</given-names></name>, <name name-style="western"><surname>Magnol</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Inducing segmental aneuploid mosaicism in the mouse through targeted asymmetric sister chromatid event of recombination</article-title>. <source/><italic>Genetics</italic>
<volume>180</volume>, <fpage>51</fpage>-<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.108.092312</pub-id><pub-id pub-id-type="pmid">18757940</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pothion</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Brault</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Tybulewicz</surname><given-names>V. L. J.</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>E. M. C.</given-names></name> and <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name></person-group> (<year>2011a</year>). <article-title>The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome</article-title>. <source/><italic>Behav. Brain Res.</italic>
<volume>217</volume>, <fpage>271</fpage>-<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2010.10.023</pub-id><pub-id pub-id-type="pmid">21047530</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Raveau</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chevalier</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Nalesso</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>A. J.</given-names></name> and <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name></person-group> (<year>2011b</year>). <article-title>Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>22</volume>, <fpage>674</fpage>-<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-011-9356-0</pub-id><pub-id pub-id-type="pmid">21953411</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faizi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bader</surname><given-names>P. L.</given-names></name>, <name name-style="western"><surname>Tun</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Encarnacion</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kleschevnikov</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Saw</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Priestley</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tsien</surname><given-names>R. W.</given-names></name>, <name name-style="western"><surname>Mobley</surname><given-names>W. C.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of beta1-adrenergic receptor by xamoterol as a potential cognitive enhancer</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>43</volume>, <fpage>397</fpage>-<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2011.04.011</pub-id><pub-id pub-id-type="pmid">21527343</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Morishita</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Zuniga</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Blank</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Malenka</surname><given-names>R. C.</given-names></name> and <name name-style="western"><surname>Garner</surname><given-names>C. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome</article-title>. <source/><italic>Nat. Neurosci.</italic>
<volume>10</volume>, <fpage>411</fpage>-<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1038/nn1860</pub-id><pub-id pub-id-type="pmid">17322876</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fortress</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Hamlett</surname><given-names>E. D.</given-names></name>, <name name-style="western"><surname>Vazey</surname><given-names>E. M.</given-names></name>, <name name-style="western"><surname>Aston-Jones</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Cass</surname><given-names>W. A.</given-names></name>, <name name-style="western"><surname>Boger</surname><given-names>H. A.</given-names></name> and <name name-style="western"><surname>Granholm</surname><given-names>A.-C. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Designer receptors enhance memory in a mouse model of Down syndrome</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>35</volume>, <fpage>1343</fpage>-<lpage>1353</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2658-14.2015</pub-id><pub-id pub-id-type="pmid">25632113</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>García-Cerro</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Martínez</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Corrales</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Flórez</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Rueda</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Arbonés</surname><given-names>M. L.</given-names></name> and <name name-style="western"><surname>Martínez-Cué</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>9</volume>, <fpage>e106572</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0106572</pub-id><pub-id pub-id-type="pmid">25188425</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghezzo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Salvioli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Solimando</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Palmieri</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Chiostergi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Scurti</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lomartire</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Bedetti</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Cocchi</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Follo</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Age-related changes of adaptive and neuropsychological features in persons with Down Syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>9</volume>, <fpage>e113111</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0113111</pub-id><pub-id pub-id-type="pmid">25419980</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giacomini</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Stagni</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Trazzi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Guidi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Emili</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Brigham</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ciani</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Bartesaghi</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>82</volume>, <fpage>385</fpage>-<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2015.08.001</pub-id><pub-id pub-id-type="pmid">26254735</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodliffe</surname><given-names>J. W.</given-names></name>, <name name-style="western"><surname>Olmos-Serrano</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Aziz</surname><given-names>N. M.</given-names></name>, <name name-style="western"><surname>Pennings</surname><given-names>J. L. A.</given-names></name>, <name name-style="western"><surname>Guedj</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Bianchi</surname><given-names>D. W.</given-names></name> and <name name-style="western"><surname>Haydar</surname><given-names>T. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Absence of prenatal forebrain defects in the Dp(16)1Yey/+ mouse model of Down syndrome</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>36</volume>, <fpage>2926</fpage>-<lpage>2944</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2513-15.2016</pub-id><pub-id pub-id-type="pmid">26961948</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Granholm</surname><given-names>A.-C. E.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>L. A.</given-names></name> and <name name-style="western"><surname>Crnic</surname><given-names>L. S.</given-names></name></person-group> (<year>2000</year>). <article-title>Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome</article-title>. <source/><italic>Exp. Neurol.</italic>
<volume>161</volume>, <fpage>647</fpage>-<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1006/exnr.1999.7289</pub-id><pub-id pub-id-type="pmid">10686084</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Granholm</surname><given-names>A.-C. E.</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>K. A.</given-names></name>, <name name-style="western"><surname>Hyde</surname><given-names>L. A.</given-names></name>, <name name-style="western"><surname>Bimonte</surname><given-names>H. A.</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>C. L.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Albeck</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>L. A.</given-names></name>, <name name-style="western"><surname>Mufson</surname><given-names>E. J.</given-names></name> and <name name-style="western"><surname>Crnic</surname><given-names>L. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome</article-title>. <source/><italic>Physiol. Behav.</italic>
<volume>77</volume>, <fpage>371</fpage>-<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9384(02)00884-3</pub-id><pub-id pub-id-type="pmid">12419414</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Granholm</surname><given-names>A.-C.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Seo</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Isacson</surname><given-names>O.</given-names></name></person-group> (<year>2003</year>). <article-title>Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome</article-title>. <source/><italic>Hippocampus</italic>
<volume>13</volume>, <fpage>905</fpage>-<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.10130</pub-id><pub-id pub-id-type="pmid">14750653</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grau</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Arató</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Fernández-Fernández</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Valderrama</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sindreu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Fillat</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ferrer</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>DE</surname><given-names>L. A.</given-names></name><name name-style="western"><surname>Luna</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Altafaj</surname><given-names>X.</given-names></name></person-group> (<year>2014</year>). <article-title>DYRK1A-mediated phosphorylation of GluN2A at Ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors</article-title>. <source/><italic>Front. Cell Neurosci.</italic>
<volume>8</volume>, <fpage>331</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00331</pub-id><pub-id pub-id-type="pmid">25368549</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gribble</surname><given-names>S. M.</given-names></name>, <name name-style="western"><surname>Wiseman</surname><given-names>F. K.</given-names></name>, <name name-style="western"><surname>Clayton</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Prigmore</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Langley</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Maguire</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Rajan</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sheppard</surname><given-names>O.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>8</volume>, <fpage>e60482</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0060482</pub-id><pub-id pub-id-type="pmid">23596509</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gropp</surname><given-names>A.</given-names></name></person-group> (<year>1974</year>). <article-title>Animal model of human disease. Autosomal trisomy, developmental impairment and fetal death</article-title>. <source/><italic>Am. J. Pathol.</italic>
<volume>77</volume>, <fpage>539</fpage>-<lpage>542</lpage>.<pub-id pub-id-type="pmid">4473901</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gropp</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kolbus</surname><given-names>U.</given-names></name> and <name name-style="western"><surname>Giers</surname><given-names>D.</given-names></name></person-group> (<year>1975</year>). <article-title>Systematic approach to the study of trisomy in the mouse. II</article-title>. <source/><italic>Cytogenet. Cell Genet.</italic>
<volume>14</volume>, <fpage>42</fpage>-<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1159/000130318</pub-id><pub-id pub-id-type="pmid">1132247</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guedj</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Sébrié</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Rivals</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Ledru</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Paly</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Bizot</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Gillet</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Arbones</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A</article-title>. <source/><italic>PLoS ONE</italic>
<volume>4</volume>, <fpage>e4606</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0004606</pub-id><pub-id pub-id-type="pmid">19242551</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guedj</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>P. L.</given-names></name>, <name name-style="western"><surname>Najas</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Barallobre</surname><given-names>M.-J.</given-names></name>, <name name-style="western"><surname>Chabert</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Souchet</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Sebrie</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Verney</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Arbones</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>DYRK1A: a master regulatory protein controlling brain growth</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>46</volume>, <fpage>190</fpage>-<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.01.007</pub-id><pub-id pub-id-type="pmid">22293606</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guedj</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Pennings</surname><given-names>J. L. A.</given-names></name>, <name name-style="western"><surname>Massingham</surname><given-names>L. J.</given-names></name>, <name name-style="western"><surname>Wick</surname><given-names>H. C.</given-names></name>, <name name-style="western"><surname>Siegel</surname><given-names>A. E.</given-names></name>, <name name-style="western"><surname>Tantravahi</surname><given-names>U.</given-names></name> and <name name-style="western"><surname>Bianchi</surname><given-names>D. W.</given-names></name></person-group> (<year>2016</year>). <article-title>An integrated human/murine transcriptome and pathway approach to identify prenatal treatments for Down syndrome</article-title>. <source/><italic>Sci. Rep.</italic>
<volume>6</volume>, <fpage>32353</fpage>
<pub-id pub-id-type="doi">10.1038/srep32353</pub-id><pub-id pub-id-type="pmid">27586445</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guidi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Stagni</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Bianchi</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Ciani</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Giacomini</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>De Franceschi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Moldrich</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kurniawan</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Mardon</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Giuliani</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model</article-title>. <source/><italic>Brain</italic>
<volume>137</volume>, <fpage>380</fpage>-<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awt340</pub-id><pub-id pub-id-type="pmid">24334313</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dhanasekaran</surname><given-names>A. R.</given-names></name> and <name name-style="western"><surname>Gardiner</surname><given-names>K. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Mouse models of Down syndrome: gene content and consequences</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>27</volume>, <fpage>538</fpage>-<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-016-9661-8</pub-id><pub-id pub-id-type="pmid">27538963</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gutierrez-Castellanos</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Winkelman</surname><given-names>B. H. J.</given-names></name>, <name name-style="western"><surname>Tolosa-Rodriguez</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Devenney</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name> and <name name-style="western"><surname>De Zeeuw</surname><given-names>C. I.</given-names></name></person-group> (<year>2013</year>). <article-title>Size does not always matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal SAG treatment</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>33</volume>, <fpage>15408</fpage>-<lpage>15413</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2198-13.2013</pub-id><pub-id pub-id-type="pmid">24068809</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haas</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Slender</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lana-Elola</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Watson-Scales</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>E. M. C.</given-names></name>, <name name-style="western"><surname>Tybulewicz</surname><given-names>V. L. J.</given-names></name> and <name name-style="western"><surname>Guillemot</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Alterations to dendritic spine morphology, but not dendrite patterning, of cortical projection neurons in Tc1 and Ts1Rhr mouse models of Down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>8</volume>, <fpage>e78561</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0078561</pub-id><pub-id pub-id-type="pmid">24205261</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Wiseman</surname><given-names>F. K.</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>E. M. C.</given-names></name>, <name name-style="western"><surname>Tybulewicz</surname><given-names>V. L. J.</given-names></name>, <name name-style="western"><surname>Harwood</surname><given-names>J. L.</given-names></name> and <name name-style="western"><surname>Good</surname><given-names>M. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Tc1 mouse model of trisomy-21 dissociates properties of short- and long-term recognition memory</article-title>. <source/><italic>Neurobiol. Learn. Mem.</italic>
<volume>130</volume>, <fpage>118</fpage>-<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2016.02.002</pub-id><pub-id pub-id-type="pmid">26868479</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamlett</surname><given-names>E. D.</given-names></name>, <name name-style="western"><surname>Boger</surname><given-names>H. A.</given-names></name>, <name name-style="western"><surname>Ledreux</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Mufson</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Falangola</surname><given-names>M. F.</given-names></name>, <name name-style="western"><surname>Guilfoyle</surname><given-names>D. N.</given-names></name>, <name name-style="western"><surname>Nixon</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Duval</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Cognitive impairment, neuroimaging, and Alzheimer neuropathology in mouse models of Down syndrome</article-title>. <source/><italic>Curr. Alzheimer Res.</italic>
<volume>13</volume>, <fpage>35</fpage>-<lpage>52</lpage>. <pub-id pub-id-type="doi">10.2174/1567205012666150921095505</pub-id><pub-id pub-id-type="pmid">26391050</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanson</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Meilandt</surname><given-names>W. J.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Luu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Shamloo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Scearce-Levie</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Zhou</surname><given-names>Q.</given-names></name></person-group> (<year>2013</year>). <article-title>GluN2B antagonism affects interneurons and leads to immediate and persistent changes in synaptic plasticity, oscillations, and behavior</article-title>. <source/><italic>Neuropsychopharmacology</italic>
<volume>38</volume>, <fpage>1221</fpage>-<lpage>1233</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2013.19</pub-id><pub-id pub-id-type="pmid">23340518</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Head</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lott</surname><given-names>I. T.</given-names></name>, <name name-style="western"><surname>Wilcock</surname><given-names>D. M.</given-names></name> and <name name-style="western"><surname>Lemere</surname><given-names>C. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology</article-title>. <source/><italic>Curr. Alzheimer Res.</italic>
<volume>13</volume>, <fpage>18</fpage>-<lpage>29</lpage>. <pub-id pub-id-type="doi">10.2174/1567205012666151020114607</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heinen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hettich</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>D. P.</given-names></name>, <name name-style="western"><surname>Schnell</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Paesler</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Ehninger</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Neural Plast.</italic>
<volume>2012</volume>, <fpage>467251</fpage>
<pub-id pub-id-type="doi">10.1155/2012/467251</pub-id><pub-id pub-id-type="pmid">22848851</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Rassoulzadegan</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cuzin</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Duboule</surname><given-names>D.</given-names></name></person-group> (<year>1998</year>). <article-title>Engineering chromosomes in mice through targeted meiotic recombination (TAMERE)</article-title>. <source/><italic>Nat. Genet.</italic>
<volume>20</volume>, <fpage>381</fpage>-<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/3861</pub-id><pub-id pub-id-type="pmid">9843213</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Velot</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Maréchal</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Brault</surname><given-names>V.</given-names></name></person-group> (<year>2012</year>). <article-title>The in vivo Down syndrome genomic library in mouse</article-title>. <source/><italic>Prog. Brain Res.</italic>
<volume>197</volume>, <fpage>169</fpage>-<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-54299-1.00009-1</pub-id><pub-id pub-id-type="pmid">22541293</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hervé</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Coussement</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Dumont</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Jacques</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Cuisset</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Chicard</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hizem</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bourdoncle</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Letourneur</surname><given-names>F.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Aneuploidy: the impact of chromosome imbalance on nuclear organization and overall genome expression</article-title>. <source/><italic>Clin. Genet.</italic>
<volume>90</volume>, <fpage>35</fpage>-<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12731</pub-id><pub-id pub-id-type="pmid">27283765</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>R. N.</given-names></name></person-group> (<year>2004</year>). <article-title>The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory</article-title>. <source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>28</volume>, <fpage>497</fpage>-<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2004.06.006</pub-id><pub-id pub-id-type="pmid">15465137</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunter</surname><given-names>C. L.</given-names></name>, <name name-style="western"><surname>Bachman</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Granholm</surname><given-names>A.-C.</given-names></name></person-group> (<year>2004a</year>). <article-title>Minocycline prevents cholinergic loss in a mouse model of Down's syndrome</article-title>. <source/><italic>Ann. Neurol.</italic>
<volume>56</volume>, <fpage>675</fpage>-<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20250</pub-id><pub-id pub-id-type="pmid">15468085</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunter</surname><given-names>C. L.</given-names></name>, <name name-style="western"><surname>Bimonte-Nelson</surname><given-names>H. A.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Eckman</surname><given-names>C. B.</given-names></name> and <name name-style="western"><surname>Granholm</surname><given-names>A.-C.</given-names></name></person-group> (<year>2004b</year>). <article-title>Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen</article-title>. <source/><italic>Neurobiol. Aging</italic>
<volume>25</volume>, <fpage>873</fpage>-<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2003.10.010</pub-id><pub-id pub-id-type="pmid">15212841</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ichinohe</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kanaumi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Takashima</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Enokido</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Nagai</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Kimura</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Cystathionine beta-synthase is enriched in the brains of Down's patients</article-title>. <source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>338</volume>, <fpage>1547</fpage>-<lpage>1550</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2005.10.118</pub-id><pub-id pub-id-type="pmid">16274669</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Incerti</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Toso</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Vink</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Roberson</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Nold</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Abebe</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Spong</surname><given-names>C. Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Prevention of learning deficit in a Down syndrome model</article-title>. <source/><italic>Obstet. Gynecol.</italic>
<volume>117</volume>, <fpage>354</fpage>-<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1097/AOG.0b013e3182051ca5</pub-id><pub-id pub-id-type="pmid">21252750</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Incerti</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Horowitz</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Roberson</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Abebe</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Toso</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Caballero</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Spong</surname><given-names>C. Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Prenatal treatment prevents learning deficit in Down syndrome model</article-title>. <source/><italic>PLoS ONE</italic>
<volume>7</volume>, <fpage>e50724</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0050724</pub-id><pub-id pub-id-type="pmid">23209818</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inglis</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hippman</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Austin</surname><given-names>J. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Prenatal testing for Down syndrome: the perspectives of parents of individuals with Down syndrome</article-title>. <source/><italic>Am. J. Med. Genet. A</italic>
<volume>158A</volume>, <fpage>743</fpage>-<lpage>750</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35238</pub-id><pub-id pub-id-type="pmid">22354662</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Hui</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Hedgehog signaling in development and cancer</article-title>. <source/><italic>Dev. Cell</italic>
<volume>15</volume>, <fpage>801</fpage>-<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2008.11.010</pub-id><pub-id pub-id-type="pmid">19081070</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Kleschevnikov</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Pao</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Peresie</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Genetic dissection of the Down syndrome critical region</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>24</volume>, <fpage>6540</fpage>-<lpage>6551</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv364</pub-id><pub-id pub-id-type="pmid">26374847</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Rigoglioso</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Peterhoff</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Pawlik</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Bleiwas</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Stavrides</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Smiley</surname><given-names>J. F.</given-names></name>, <name name-style="western"><surname>Ginsberg</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>P. M.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF</article-title>. <source/><italic>Neurobiol. Aging</italic>
<volume>39</volume>, <fpage>90</fpage>-<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.11.013</pub-id><pub-id pub-id-type="pmid">26923405</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joshi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Michaeli</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Salter</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Thibault-Messier</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Hashmi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Eubanks</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Cortez</surname><given-names>M. A.</given-names></name> and <name name-style="western"><surname>Snead</surname><given-names>O. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Infantile spasms in Down syndrome: rescue by knockdown of the GIRK2 channel</article-title>. <source/><italic>Ann. Neurol.</italic>
<volume>80</volume>, <fpage>511</fpage>-<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24749</pub-id><pub-id pub-id-type="pmid">27462820</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karmiloff-Smith</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Al-Janabi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>D'souza</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Groet</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Massand</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mok</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Startin</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Hardy</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Nizetic</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>The importance of understanding individual differences in Down syndrome</article-title>. <source/><italic>F1000Res</italic>
<volume>5</volume>, <fpage>389</fpage>
<pub-id pub-id-type="doi">10.12688/f1000research.7506.1</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelley</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Ash</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Powers</surname><given-names>B. E.</given-names></name>, <name name-style="western"><surname>Velazquez</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Alldred</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Ikonomovic</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Ginsberg</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Strupp</surname><given-names>B. J.</given-names></name> and <name name-style="western"><surname>Mufson</surname><given-names>E. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Effects of maternal choline supplementation on the septohippocampal cholinergic system in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Curr. Alzheimer Res.</italic>
<volume>13</volume>, <fpage>84</fpage>-<lpage>96</lpage>. <pub-id pub-id-type="doi">10.2174/1567205012666150921100515</pub-id><pub-id pub-id-type="pmid">26391045</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kern</surname><given-names>D. S.</given-names></name>, <name name-style="western"><surname>Maclean</surname><given-names>K. N.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Synder</surname><given-names>E. Y.</given-names></name>, <name name-style="western"><surname>Sladek</surname><given-names>J. R.</given-names><suffix>Jr.</suffix></name> and <name name-style="western"><surname>Bjugstad</surname><given-names>K. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice</article-title>. <source/><italic>Cell Transplant.</italic>
<volume>20</volume>, <fpage>371</fpage>-<lpage>379</lpage>. <pub-id pub-id-type="doi">10.3727/096368910X528085</pub-id><pub-id pub-id-type="pmid">20875225</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khoshnood</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Greenlees</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Loane</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dolk</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Committee</surname><given-names>E. P. M.</given-names></name> and <name name-style="western"><surname>Group</surname><given-names>E. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Paper 2: EUROCAT public health indicators for congenital anomalies in Europe</article-title>. <source/><italic>Birth Defects Res. A Clin. Mol. Teratol</italic>
<volume>91</volume>
<issue>Suppl. 1</issue>, <fpage>S16</fpage>-<lpage>S22</lpage>. <pub-id pub-id-type="doi">10.1002/bdra.20776</pub-id><pub-id pub-id-type="pmid">21381186</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kida</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Rabe</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Walus</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Albertini</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Golabek</surname><given-names>A. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn</article-title>. <source/><italic>Exp. Neurol.</italic>
<volume>240</volume>, <fpage>178</fpage>-<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2012.11.022</pub-id><pub-id pub-id-type="pmid">23201095</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleschevnikov</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Villar</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Epstein</surname><given-names>C. J.</given-names></name>, <name name-style="western"><surname>Malenka</surname><given-names>R. C.</given-names></name> and <name name-style="western"><surname>Mobley</surname><given-names>W. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>24</volume>, <fpage>8153</fpage>-<lpage>8160</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1766-04.2004</pub-id><pub-id pub-id-type="pmid">15371516</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleschevnikov</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Faizi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>L. F.</given-names></name>, <name name-style="western"><surname>Htun</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Shamloo</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Mobley</surname><given-names>W. C.</given-names></name></person-group> (<year>2012a</year>). <article-title>Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>32</volume>, <fpage>9217</fpage>-<lpage>9227</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1673-12.2012</pub-id><pub-id pub-id-type="pmid">22764230</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleschevnikov</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Gall</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>George</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Nosheny</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Maloney</surname><given-names>M. T.</given-names></name>, <name name-style="western"><surname>Salehi</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Mobley</surname><given-names>W. C.</given-names></name></person-group> (<year>2012b</year>). <article-title>Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>45</volume>, <fpage>683</fpage>-<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2011.10.009</pub-id><pub-id pub-id-type="pmid">22062771</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korbel</surname><given-names>J. O.</given-names></name>, <name name-style="western"><surname>Tirosh-Wagner</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Urban</surname><given-names>A. E.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.-N.</given-names></name>, <name name-style="western"><surname>Kasowski</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Grubert</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Erdman</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Lange</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>106</volume>, <fpage>12031</fpage>-<lpage>12036</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0813248106</pub-id><pub-id pub-id-type="pmid">19597142</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korenberg</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X. N.</given-names></name>, <name name-style="western"><surname>Schipper</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Gonsky</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gerwehr</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Carpenter</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Daumer</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Dignan</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Disteche</surname><given-names>C.</given-names></name></person-group> (<year>1994</year>). <article-title>Down syndrome phenotypes: the consequences of chromosomal imbalance</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>91</volume>, <fpage>4997</fpage>-<lpage>5001</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.91.11.4997</pub-id><pub-id pub-id-type="pmid">8197171</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krinsky-Mchale</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Devenny</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Jenkins</surname><given-names>E. C.</given-names></name>, <name name-style="western"><surname>Kittler</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Murty</surname><given-names>V. V.</given-names></name>, <name name-style="western"><surname>Schupf</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Scotto</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Tycko</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Urv</surname><given-names>T. K.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Successful aging in a 70-year-old man with down syndrome: a case study</article-title>. <source/><italic>Intellect. Dev. Disabil.</italic>
<volume>46</volume>, <fpage>215</fpage>-<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1352/2008.46:215-228</pub-id><pub-id pub-id-type="pmid">18578579</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kruszka</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Porras</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Sobering</surname><given-names>A. K.</given-names></name>, <name name-style="western"><surname>Ikolo</surname><given-names>F. A.</given-names></name>, <name name-style="western"><surname>La Qua</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shotelersuk</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>B. H. Y.</given-names></name>, <name name-style="western"><surname>Mok</surname><given-names>G. T. K.</given-names></name>, <name name-style="western"><surname>Uwineza</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Mutesa</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>). <article-title>Down syndrome in diverse populations</article-title>. <source/><italic>Am. J. Med. Genet. A</italic>
<volume>173</volume>, <fpage>42</fpage>-<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38043</pub-id><pub-id pub-id-type="pmid">27991738</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laffaire</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rivals</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Dauphinot</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Pasteau</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Wehrle</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Larrat</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Vitalis</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Moldrich</surname><given-names>R. X.</given-names></name>, <name name-style="western"><surname>Rossier</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sinkus</surname><given-names>R.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development</article-title>. <source/><italic>BMC Genomics</italic>
<volume>10</volume>, <fpage>138</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-10-138</pub-id><pub-id pub-id-type="pmid">19331679</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laguna</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Barallobre</surname><given-names>M.-J.</given-names></name>, <name name-style="western"><surname>Marchena</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mateus</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ramírez</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Martínez-Cue</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Delabar</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Castelo-Branco</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>de la Villa</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Arbonés</surname><given-names>M. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>, <fpage>2775</fpage>-<lpage>2784</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt125</pub-id><pub-id pub-id-type="pmid">23512985</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lana-Elola</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Watson-Scales</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Slender</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gibbins</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Martineau</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Douglas</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mohun</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>E. M. C.</given-names></name> and <name name-style="western"><surname>Tybulewicz</surname><given-names>V. L. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel</article-title>. <source/><italic>Elife</italic>
<volume>5</volume>, <fpage>e11614</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.11614</pub-id><pub-id pub-id-type="pmid">26765563</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Latchney</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Jaramillo</surname><given-names>T. C.</given-names></name>, <name name-style="western"><surname>Rivera</surname><given-names>P. D.</given-names></name>, <name name-style="western"><surname>Eisch</surname><given-names>A. J.</given-names></name> and <name name-style="western"><surname>Powell</surname><given-names>C. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Chronic P7C3 treatment restores hippocampal neurogenesis in the Ts65Dn mouse model of Down Syndrome [Corrected]</article-title>. <source/><italic>Neurosci. Lett.</italic>
<volume>591</volume>, <fpage>86</fpage>-<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2015.02.008</pub-id><pub-id pub-id-type="pmid">25668489</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>D.-S.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Shin</surname><given-names>H.-S.</given-names></name></person-group> (<year>2011</year>). <article-title>Bidirectional modulation of fear extinction by mediodorsal thalamic firing in mice</article-title>. <source/><italic>Nat. Neurosci.</italic>
<volume>15</volume>, <fpage>308</fpage>-<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2999</pub-id><pub-id pub-id-type="pmid">22197828</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Letourneau</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Santoni</surname><given-names>F. A.</given-names></name>, <name name-style="western"><surname>Bonilla</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Sailani</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Kind</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chevalier</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Thurman</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sandstrom</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Hibaoui</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Domains of genome-wide gene expression dysregulation in Down's syndrome</article-title>. <source/><italic>Nature</italic>
<volume>508</volume>, <fpage>345</fpage>-<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1038/nature13200</pub-id><pub-id pub-id-type="pmid">24740065</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Morishima</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pao</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Laduca</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Conroy</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Nowak</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Matsui</surname><given-names>S.-I.</given-names></name>, <name name-style="western"><surname>Shiraishi</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Yu</surname><given-names>Y. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>16</volume>, <fpage>1359</fpage>-<lpage>1366</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm086</pub-id><pub-id pub-id-type="pmid">17412756</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Edie</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Klinedinst</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Blackshaw</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Maslen</surname><given-names>C. L.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Penetrance of congenital heart disease in a mouse model of Down syndrome depends on a trisomic potentiator of a disomic modifier</article-title>. <source/><italic>Genetics</italic>
<volume>203</volume>, <fpage>763</fpage>-<lpage>770</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.116.188045</pub-id><pub-id pub-id-type="pmid">27029737</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lignon</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Bichler</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Hivert</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Gannier</surname><given-names>F. E.</given-names></name>, <name name-style="western"><surname>Cosnay</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Del Rio</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Migliore-Samour</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Malécot</surname><given-names>C. O.</given-names></name></person-group> (<year>2008</year>). <article-title>Altered heart rate control in transgenic mice carrying the KCNJ6 gene of the human chromosome 21</article-title>. <source/><italic>Physiol. Genomics</italic>
<volume>33</volume>, <fpage>230</fpage>-<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1152/physiolgenomics.00143.2007</pub-id><pub-id pub-id-type="pmid">18303085</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Morishima</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Matsui</surname><given-names>S.-I.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Pao</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>A. C.</given-names></name>, <name name-style="western"><surname>Gardiner</surname><given-names>K. J.</given-names></name>, <name name-style="western"><surname>Cowell</surname><given-names>J. K.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Genetic analysis of Down syndrome-associated heart defects in mice</article-title>. <source/><italic>Hum. Genet.</italic>
<volume>130</volume>, <fpage>623</fpage>-<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-011-0980-2</pub-id><pub-id pub-id-type="pmid">21442329</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Morishima</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ray</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Pao</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Parmacek</surname><given-names>M. S.</given-names></name> and <name name-style="western"><surname>Yu</surname><given-names>Y. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice</article-title>. <source/><italic>Hum. Genet.</italic>
<volume>133</volume>, <fpage>743</fpage>-<lpage>753</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-013-1407-z</pub-id><pub-id pub-id-type="pmid">24362460</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Llorens-Martín</surname><given-names>M. V.</given-names></name>, <name name-style="western"><surname>Rueda</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Tejeda</surname><given-names>G. S.</given-names></name>, <name name-style="western"><surname>Flórez</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Trejo</surname><given-names>J. L.</given-names></name> and <name name-style="western"><surname>Martínez-Cué</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome</article-title>. <source/><italic>Neuroscience</italic>
<volume>171</volume>, <fpage>1228</fpage>-<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.09.043</pub-id><pub-id pub-id-type="pmid">20875841</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loane</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>J. K.</given-names></name>, <name name-style="western"><surname>Addor</surname><given-names>M.-C.</given-names></name>, <name name-style="western"><surname>Arriola</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Budd</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Doray</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Garne</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Gatt</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Haeusler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Khoshnood</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening</article-title>. <source/><italic>Eur. J. Hum. Genet.</italic>
<volume>21</volume>, <fpage>27</fpage>-<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2012.94</pub-id><pub-id pub-id-type="pmid">22713804</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lockrow</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Prakasam</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Bimonte-Nelson</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sambamurti</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Granholm</surname><given-names>A.-C.</given-names></name></person-group> (<year>2009</year>). <article-title>Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model</article-title>. <source/><italic>Exp. Neurol.</italic>
<volume>216</volume>, <fpage>278</fpage>-<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2008.11.021</pub-id><pub-id pub-id-type="pmid">19135442</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lockrow</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Boger</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Bimonte-Nelson</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Granholm</surname><given-names>A.-C.</given-names></name></person-group> (<year>2011</year>). <article-title>Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome</article-title>. <source/><italic>Behav. Brain Res.</italic>
<volume>221</volume>, <fpage>610</fpage>-<lpage>622</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2010.03.036</pub-id><pub-id pub-id-type="pmid">20363261</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopes Pereira</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Magnol</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sahún</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Brault</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Prandini</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Gruart</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bizot</surname><given-names>J.-C.</given-names></name>, <name name-style="western"><surname>Chadefaux-Vekemans</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Deutsch</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>18</volume>, <fpage>4756</fpage>-<lpage>4769</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp438</pub-id><pub-id pub-id-type="pmid">19783846</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lyle</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Béna</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gagos</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gehrig</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Schinzel</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lespinasse</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bottani</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dahoun</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Taine</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21</article-title>. <source/><italic>Eur. J. Hum. Genet.</italic>
<volume>17</volume>, <fpage>454</fpage>-<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2008.214</pub-id><pub-id pub-id-type="pmid">19002211</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lysenko</surname><given-names>L. V.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Tyrtyshnaia</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kohnz</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Madamba</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>G. M.</given-names></name>, <name name-style="western"><surname>Kleschevnikova</surname><given-names>N. E.</given-names></name>, <name name-style="western"><surname>Nomura</surname><given-names>D. K.</given-names></name>, <name name-style="western"><surname>Ezekowitz</surname><given-names>R. A. B.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>9</volume>, <fpage>e114521</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0114521</pub-id><pub-id pub-id-type="pmid">25474204</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malinge</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bliss-Moreau</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kirsammer</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Diebold</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Chlon</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Gurbuxani</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Crispino</surname><given-names>J. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome</article-title>. <source/><italic>J. Clin. Invest.</italic>
<volume>122</volume>, <fpage>948</fpage>-<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1172/JCI60455</pub-id><pub-id pub-id-type="pmid">22354171</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marechal</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lopes Pereira</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Dosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>10</volume>, <fpage>e0115302</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0115302</pub-id><pub-id pub-id-type="pmid">25706610</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez-Cue</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Rueda</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Corrales</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Montero</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Pazos</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Florez</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Reducing GABAA alpha5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of Down syndrome</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>33</volume>, <fpage>3953</fpage>-<lpage>3966</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1203-12.2013</pub-id><pub-id pub-id-type="pmid">23447605</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez de Lagrán</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Altafaj</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Gallego</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Martí</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Estivill</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Sahún</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Fillat</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>15</volume>, <fpage>132</fpage>-<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2003.10.002</pub-id><pub-id pub-id-type="pmid">14751778</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mátyás</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>H.-S.</given-names></name> and <name name-style="western"><surname>Acsády</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>The fear circuit of the mouse forebrain: connections between the mediodorsal thalamus, frontal cortices and basolateral amygdala</article-title>. <source/><italic>Eur. J. Neurosci.</italic>
<volume>39</volume>, <fpage>1810</fpage>-<lpage>1823</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12610</pub-id><pub-id pub-id-type="pmid">24819022</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCann</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Hudes</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Ames</surname><given-names>B. N.</given-names></name></person-group> (<year>2006</year>). <article-title>An overview of evidence for a causal relationship between dietary availability of choline during development and cognitive function in offspring</article-title>. <source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>30</volume>, <fpage>696</fpage>-<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2005.12.003</pub-id><pub-id pub-id-type="pmid">16504295</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McElyea</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Starbuck</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Tumbleson-Brink</surname><given-names>D. M.</given-names></name>, <name name-style="western"><surname>Harrington</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Blazek</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Ghoneima</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kula</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Roper</surname><given-names>R. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>25</volume>, <fpage>4856</fpage>-<lpage>4869</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw309</pub-id><pub-id pub-id-type="pmid">28172997</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendioroz</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Do</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Darbary</surname><given-names>H. K.</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>C. F.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Abu-Amero</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Stanier</surname><given-names>P.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models</article-title>. <source/><italic>Genome Biol.</italic>
<volume>16</volume>, <fpage>263</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-015-0827-6</pub-id><pub-id pub-id-type="pmid">26607552</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moon</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gandhy</surname><given-names>S. U.</given-names></name>, <name name-style="western"><surname>Strawderman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Levitsky</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Maclean</surname><given-names>K. N.</given-names></name> and <name name-style="western"><surname>Strupp</surname><given-names>B. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Behav. Neurosci.</italic>
<volume>124</volume>, <fpage>346</fpage>-<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1037/a0019590</pub-id><pub-id pub-id-type="pmid">20528079</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>C. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>17</volume>, <fpage>1005</fpage>-<lpage>1012</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-006-0032-8</pub-id><pub-id pub-id-type="pmid">17019652</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>C. S.</given-names></name>, <name name-style="western"><surname>Hawkins</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Franca</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lawler</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Devenney</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Increased male reproductive success in Ts65Dn “Down syndrome” mice</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>21</volume>, <fpage>543</fpage>-<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-010-9300-8</pub-id><pub-id pub-id-type="pmid">21110029</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>T. H.</given-names></name>, <name name-style="western"><surname>Capone</surname><given-names>G. T.</given-names></name>, <name name-style="western"><surname>Knipp</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Davisson</surname><given-names>M. T.</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name> and <name name-style="western"><surname>Gearhart</surname><given-names>J. D.</given-names></name></person-group> (<year>2002</year>). <article-title>The effects of piracetam on cognitive performance in a mouse model of Down's syndrome</article-title>. <source/><italic>Physiol. Behav.</italic>
<volume>77</volume>, <fpage>403</fpage>-<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9384(02)00873-9</pub-id><pub-id pub-id-type="pmid">12419416</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>R.</given-names></name></person-group> (<year>1984</year>). <article-title>Developments of a water-maze procedure for studying spatial learning in the rat</article-title>. <source/><italic>J. Neurosci. Methods</italic>
<volume>11</volume>, <fpage>47</fpage>-<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/0165-0270(84)90007-4</pub-id><pub-id pub-id-type="pmid">6471907</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>J. K.</given-names></name> and <name name-style="western"><surname>Wald</surname><given-names>N. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies</article-title>. <source/><italic>J. Med. Screen</italic>
<volume>14</volume>, <fpage>5</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1258/096914107780154549</pub-id><pub-id pub-id-type="pmid">17362564</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>J. K.</given-names></name>, <name name-style="western"><surname>Wald</surname><given-names>N. J.</given-names></name> and <name name-style="western"><surname>Watt</surname><given-names>H. C.</given-names></name></person-group> (<year>1999</year>). <article-title>Fetal loss in Down syndrome pregnancies</article-title>. <source/><italic>Prenat. Diagn.</italic>
<volume>19</volume>, <fpage>142</fpage>-<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0223(199902)19:2&lt;142::AID-PD486&gt;3.0.CO;2-7</pub-id><pub-id pub-id-type="pmid">10215072</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mouton-Liger</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rattenbach</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Magnol</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Larigaldie</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Ledru</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Verney</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Créau</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca(2+) /calmodulin-dependent kinase II delta activation in mouse models of down syndrome</article-title>. <source/><italic>J. Comp. Neurol</italic>. <volume>63</volume>, <fpage>92</fpage>-<lpage>106</lpage><pub-id pub-id-type="doi">10.1002/cne.22651</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mouton-Liger</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Sahún</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Collin</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Lopes Pereira</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Masini</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Paly</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Luilier</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Même</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Jouhault</surname><given-names>Q.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Developmental molecular and functional cerebellar alterations induced by PCP4/PEP19 overexpression: implications for Down syndrome</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>63</volume>, <fpage>92</fpage>-<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.11.016</pub-id><pub-id pub-id-type="pmid">24291518</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Natoli</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Ackerman</surname><given-names>D. L.</given-names></name>, <name name-style="western"><surname>Mcdermott</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Edwards</surname><given-names>J. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011)</article-title>. <source/><italic>Prenat. Diagn.</italic>
<volume>32</volume>, <fpage>142</fpage>-<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1002/pd.2910</pub-id><pub-id pub-id-type="pmid">22418958</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Netzer</surname><given-names>W. J.</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Nong</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Blundell</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Duff</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Flajolet</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Greengard</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Lowering beta-amyloid levels rescues learning and memory in a Down syndrome mouse model</article-title>. <source/><italic>PLoS ONE</italic>
<volume>5</volume>, <fpage>e10943</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0010943</pub-id><pub-id pub-id-type="pmid">20532168</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>A. P.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Metcalf</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Hyland</surname><given-names>C. D.</given-names></name>, <name name-style="western"><surname>Ierino</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Phipson</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Baldwin</surname><given-names>T. M.</given-names></name>, <name name-style="western"><surname>Kauppi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kiu</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model</article-title>. <source/><italic>PLoS Genet.</italic>
<volume>11</volume>, <fpage>e1005211</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005211</pub-id><pub-id pub-id-type="pmid">25973911</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Doherty</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ruf</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mulligan</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hildreth</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Errington</surname><given-names>M. L.</given-names></name>, <name name-style="western"><surname>Cooke</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sesay</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Modino</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vanes</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2005</year>). <article-title>An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes</article-title>. <source/><italic>Science</italic>
<volume>309</volume>, <fpage>2033</fpage>-<lpage>2037</lpage>. <pub-id pub-id-type="doi">10.1126/science.1114535</pub-id><pub-id pub-id-type="pmid">16179473</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olmos-Serrano</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>H. J.</given-names></name>, <name name-style="western"><surname>Tyler</surname><given-names>W. A.</given-names></name>, <name name-style="western"><surname>Silbereis</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Pletikos</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jankovic-Rapan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Cramer</surname><given-names>N. P.</given-names></name>, <name name-style="western"><surname>Galdzicki</surname><given-names>Z.</given-names></name><etal>et al.</etal></person-group> (<year>2016a</year>). <article-title>Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination</article-title>. <source/><italic>Neuron</italic>
<volume>89</volume>, <fpage>1208</fpage>-<lpage>1222</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.01.042</pub-id><pub-id pub-id-type="pmid">26924435</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olmos-Serrano</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Tyler</surname><given-names>W. A.</given-names></name>, <name name-style="western"><surname>Cabral</surname><given-names>H. J.</given-names></name> and <name name-style="western"><surname>Haydar</surname><given-names>T. F.</given-names></name></person-group> (<year>2016b</year>). <article-title>Longitudinal measures of cognition in the Ts65Dn mouse: Refining windows and defining modalities for therapeutic intervention in Down syndrome</article-title>. <source/><italic>Exp. Neurol.</italic>
<volume>279</volume>, <fpage>40</fpage>-<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.02.005</pub-id><pub-id pub-id-type="pmid">26854932</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olson</surname><given-names>L. E.</given-names></name>, <name name-style="western"><surname>Richtsmeier</surname><given-names>J. T.</given-names></name>, <name name-style="western"><surname>Leszl</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2004</year>). <article-title>A chromosome 21 critical region does not cause specific Down syndrome phenotypes</article-title>. <source/><italic>Science</italic>
<volume>306</volume>, <fpage>687</fpage>-<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1126/science.1098992</pub-id><pub-id pub-id-type="pmid">15499018</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olson</surname><given-names>L. E.</given-names></name>, <name name-style="western"><surname>Roper</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Sengstaken</surname><given-names>C. L.</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>E. A.</given-names></name>, <name name-style="western"><surname>Aquino</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Galdzicki</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Siarey</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Pletnikov</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>T. H.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Trisomy for the Down syndrome ‘critical region’ is necessary but not sufficient for brain phenotypes of trisomic mice</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>16</volume>, <fpage>774</fpage>-<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm022</pub-id><pub-id pub-id-type="pmid">17339268</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ortiz-Abalia</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sahún</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Altafaj</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Andreu</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Estivill</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Fillat</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1a, a mouse model of Down syndrome</article-title>. <source/><italic>Am. J. Hum. Genet.</italic>
<volume>83</volume>, <fpage>479</fpage>-<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2008.09.010</pub-id><pub-id pub-id-type="pmid">18940310</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Blankman</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>B. F.</given-names></name> and <name name-style="western"><surname>Liu</surname><given-names>Q.-S.</given-names></name></person-group> (<year>2011</year>). <article-title>Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>31</volume>, <fpage>13420</fpage>-<lpage>13430</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2075-11.2011</pub-id><pub-id pub-id-type="pmid">21940435</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yoo</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>M.-S.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>W.-J.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S.-H.</given-names></name>, <name name-style="western"><surname>Seo</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Chung</surname><given-names>K. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>285</volume>, <fpage>31895</fpage>-<lpage>31906</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.147520</pub-id><pub-id pub-id-type="pmid">20696760</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>J. Y.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>W.-J.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Chung</surname><given-names>K. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>125</volume>, <fpage>67</fpage>-<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.086124</pub-id><pub-id pub-id-type="pmid">22250195</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parker</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Mai</surname><given-names>C. T.</given-names></name>, <name name-style="western"><surname>Canfield</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Rickard</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Kirby</surname><given-names>R. S.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006</article-title>. <source/><italic>Birth Defects Res. A Clin. Mol. Teratol</italic>
<volume>88</volume>, <fpage>1008</fpage>-<lpage>1016</lpage>. <pub-id pub-id-type="doi">10.1002/bdra.20735</pub-id><pub-id pub-id-type="pmid">20878909</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ascaño</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bodmer</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Boehm</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Bodkin-Clarke</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ryu</surname><given-names>Y. K.</given-names></name> and <name name-style="western"><surname>Kuruvilla</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>RCAN1 links impaired neurotrophin trafficking to aberrant development of the sympathetic nervous system in Down syndrome</article-title>. <source/><italic>Nat. Commun.</italic>
<volume>6</volume>, <fpage>10119</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms10119</pub-id><pub-id pub-id-type="pmid">26658127</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paylor</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Tracy</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wehner</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Rudy</surname><given-names>J. W.</given-names></name></person-group> (<year>1994</year>). <article-title>DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning</article-title>. <source/><italic>Behav. Neurosci.</italic>
<volume>108</volume>, <fpage>810</fpage>-<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1037/0735-7044.108.4.810</pub-id><pub-id pub-id-type="pmid">7986374</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peiris</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Duffield</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Fadista</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Jessup</surname><given-names>C. F.</given-names></name>, <name name-style="western"><surname>Kashmir</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Genders</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Mcgee</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Saiedi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Morton</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>A syntenic cross species aneuploidy genetic screen links RCAN1 expression to β-cell mitochondrial dysfunction in type 2 diabetes</article-title>. <source/><italic>PLoS Genet.</italic>
<volume>12</volume>, <fpage>e1006033</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1006033</pub-id><pub-id pub-id-type="pmid">27195491</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Polk</surname><given-names>R. C.</given-names></name>, <name name-style="western"><surname>Gergics</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Steimle</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Moskowitz</surname><given-names>I. P.</given-names></name>, <name name-style="western"><surname>Camper</surname><given-names>S. A.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2015</year>). <article-title>The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model</article-title>. <source/><italic>BMC Dev. Biol.</italic>
<volume>15</volume>, <fpage>30</fpage>
<pub-id pub-id-type="doi">10.1186/s12861-015-0080-y</pub-id><pub-id pub-id-type="pmid">26208718</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pons-Espinal</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Martinez de Lagran</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>60</volume>, <fpage>18</fpage>-<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.08.008</pub-id><pub-id pub-id-type="pmid">23969234</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Powell</surname><given-names>N. M.</given-names></name>, <name name-style="western"><surname>Modat</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cardoso</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>H. E.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>O'callaghan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cleary</surname><given-names>J. O.</given-names></name>, <name name-style="western"><surname>Sinclair</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wiseman</surname><given-names>F. K.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Fully-automated μMRI morphometric phenotyping of the Tc1 mouse model of Down syndrome</article-title>. <source/><italic>PLoS One</italic>
<volume>11</volume>, <fpage>e0162974</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0162974</pub-id><pub-id pub-id-type="pmid">27658297</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rachdi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kariyawasam</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Aïello</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Janel</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Delabar</surname><given-names>J.-M.</given-names></name>, <name name-style="western"><surname>Polak</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Scharfmann</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance</article-title>. <source/><italic>Cell Cycle</italic>
<volume>13</volume>, <fpage>2221</fpage>-<lpage>2229</lpage>. <pub-id pub-id-type="doi">10.4161/cc.29250</pub-id><pub-id pub-id-type="pmid">24870561</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rachidi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lopes</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Vayssettes</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>E. M.</given-names></name> and <name name-style="western"><surname>Delabar</surname><given-names>J. M.</given-names></name></person-group> (<year>2007</year>). <article-title>New cerebellar phenotypes in YAC transgenic mouse in vivo library of human Down syndrome critical region-1</article-title>. <source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>364</volume>, <fpage>488</fpage>-<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.10.035</pub-id><pub-id pub-id-type="pmid">17963726</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rachubinski</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Crowley</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Sladek</surname><given-names>J. R.</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Maclean</surname><given-names>K. N.</given-names></name> and <name name-style="western"><surname>Bjugstad</surname><given-names>K. B.</given-names></name></person-group> (<year>2012a</year>). <article-title>Effects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the Ts65Dn model of Down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>7</volume>, <fpage>e36082</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0036082</pub-id><pub-id pub-id-type="pmid">22558337</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rachubinski</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Maclean</surname><given-names>K. N.</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>J. R.</given-names></name> and <name name-style="western"><surname>Bjugstad</surname><given-names>K. B.</given-names></name></person-group> (<year>2012b</year>). <article-title>Modulating cognitive deficits and tau accumulation in a mouse model of aging Down syndrome through neonatal implantation of neural progenitor cells</article-title>. <source/><italic>Exp. Gerontol.</italic>
<volume>47</volume>, <fpage>723</fpage>-<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2012.06.013</pub-id><pub-id pub-id-type="pmid">22776132</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahmani</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Blouin</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Creau-Goldberg</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>P. C.</given-names></name>, <name name-style="western"><surname>Mattei</surname><given-names>J. F.</given-names></name>, <name name-style="western"><surname>Poissonnier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Prieur</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chettouh</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Nicole</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Aurias</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>1989</year>). <article-title>Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>86</volume>, <fpage>5958</fpage>-<lpage>5962</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.86.15.5958</pub-id><pub-id pub-id-type="pmid">2527368</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramirez-Solis</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Bradley</surname><given-names>A.</given-names></name></person-group> (<year>1995</year>). <article-title>Chromosome engineering in mice</article-title>. <source/><italic>Nature</italic>
<volume>378</volume>, <fpage>720</fpage>-<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1038/378720a0</pub-id><pub-id pub-id-type="pmid">7501018</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raveau</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lignon</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Nalesso</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Groner</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Dembele</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Brault</surname><given-names>V.</given-names></name> and <name name-style="western"><surname>Hérault</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>The app-runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a down syndrome mouse model</article-title>. <source/><italic>PLoS Genet.</italic>
<volume>8</volume>, <fpage>e1002724</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002724</pub-id><pub-id pub-id-type="pmid">22693452</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raveau</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nakahari</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Asada</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ishihara</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Amano</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Shimohata</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sago</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Yamakawa</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Brain ventriculomegaly in Down syndrome mice is caused by Pcp4 dose-dependent cilia dysfunction</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>26</volume>, <fpage>923</fpage>-<lpage>931</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx007</pub-id><pub-id pub-id-type="pmid">28069794</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name>, <name name-style="western"><surname>Irving</surname><given-names>N. G.</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>T. H.</given-names></name>, <name name-style="western"><surname>Wohn</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kitt</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sisodia</surname><given-names>S. S.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bronson</surname><given-names>R. T.</given-names></name> and <name name-style="western"><surname>Davisson</surname><given-names>M. T.</given-names></name></person-group> (<year>1995</year>). <article-title>A mouse model for Down syndrome exhibits learning and behaviour deficits</article-title>. <source/><italic>Nat. Genet.</italic>
<volume>11</volume>, <fpage>177</fpage>-<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1038/ng1095-177</pub-id><pub-id pub-id-type="pmid">7550346</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Régnier</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Billard</surname><given-names>J.-M.</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Potier</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Woerner</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Paly</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ledru</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>David</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Luilier</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bizot</surname><given-names>J.-C.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Brain phenotype of transgenic mice overexpressing cystathionine β-synthase</article-title>. <source/><italic>PLoS One</italic>
<volume>7</volume>, <fpage>e29056</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0029056</pub-id><pub-id pub-id-type="pmid">22253703</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinholdt</surname><given-names>L. G.</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>G. J.</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>G. T.</given-names></name>, <name name-style="western"><surname>Czechanski</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Solzak</surname><given-names>J. P.</given-names></name>, <name name-style="western"><surname>Roper</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>M. T.</given-names></name>, <name name-style="western"><surname>Donahue</surname><given-names>L. R.</given-names></name>, <name name-style="western"><surname>Lutz</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>22</volume>, <fpage>685</fpage>-<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-011-9357-z</pub-id><pub-id pub-id-type="pmid">21953412</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reynolds</surname><given-names>L. E.</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>T. A.</given-names></name>, <name name-style="western"><surname>D'amico</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Joffre</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Garrido-Urbani</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rodriguez-Manzaneque</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Martino-Echarri</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome</article-title>. <source/><italic>Nature</italic>
<volume>465</volume>, <fpage>813</fpage>-<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1038/nature09106</pub-id><pub-id pub-id-type="pmid">20535211</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richtsmeier</surname><given-names>J. T.</given-names></name>, <name name-style="western"><surname>Baxter</surname><given-names>L. L.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice</article-title>. <source/><italic>Dev. Dyn.</italic>
<volume>217</volume>, <fpage>137</fpage>-<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(200002)217:2&lt;137::AID-DVDY1&gt;3.0.CO;2-N</pub-id><pub-id pub-id-type="pmid">10706138</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richtsmeier</surname><given-names>J. T.</given-names></name>, <name name-style="western"><surname>Zumwalt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Carlson</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Epstein</surname><given-names>C. J.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2002</year>). <article-title>Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome</article-title>. <source/><italic>Am. J. Med. Genet.</italic>
<volume>107</volume>, <fpage>317</fpage>-<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.10175</pub-id><pub-id pub-id-type="pmid">11840489</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roizen</surname><given-names>N. J.</given-names></name> and <name name-style="western"><surname>Patterson</surname><given-names>D.</given-names></name></person-group> (<year>2003</year>). <article-title>Down's syndrome</article-title>. <source/><italic>Lancet</italic>
<volume>361</volume>, <fpage>1281</fpage>-<lpage>1289</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(03)12987-X</pub-id><pub-id pub-id-type="pmid">12699967</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roper</surname><given-names>R. J.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Understanding the basis for Down syndrome phenotypes</article-title>. <source/><italic>PLoS Genet.</italic>
<volume>2</volume>, <fpage>e50</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.0020050</pub-id><pub-id pub-id-type="pmid">16596169</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roper</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Baxter</surname><given-names>L. L.</given-names></name>, <name name-style="western"><surname>Saran</surname><given-names>N. G.</given-names></name>, <name name-style="western"><surname>Klinedinst</surname><given-names>D. K.</given-names></name>, <name name-style="western"><surname>Beachy</surname><given-names>P. A.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>103</volume>, <fpage>1452</fpage>-<lpage>1456</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510750103</pub-id><pub-id pub-id-type="pmid">16432181</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roubertoux</surname><given-names>P. L.</given-names></name>, <name name-style="western"><surname>Bichler</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Pinoteau</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Jamon</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sérégaza</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Migliore-Samour</surname><given-names>D.</given-names></name></person-group> (<year>2006</year>). <article-title>Pre-weaning sensorial and motor development in mice transpolygenic for the critical region of trisomy 21</article-title>. <source/><italic>Behav. Genet.</italic>
<volume>36</volume>, <fpage>377</fpage>-<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1007/s10519-006-9055-x</pub-id><pub-id pub-id-type="pmid">16514474</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rovelet-Lecrux</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hannequin</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Raux</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Le Meur</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Laquerrière</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Vital</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dumanchin</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Feuillette</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Brice</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Vercelletto</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2006</year>). <article-title>APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy</article-title>. <source/><italic>Nat. Genet.</italic>
<volume>38</volume>, <fpage>24</fpage>-<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/ng1718</pub-id><pub-id pub-id-type="pmid">16369530</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rovelet-Lecrux</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Frebourg</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Tuominen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Majamaa</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Campion</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Remes</surname><given-names>A. M.</given-names></name></person-group> (<year>2007</year>). <article-title>APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage</article-title>. <source/><italic>J. Neurol. Neurosurg. Psychiatry</italic>
<volume>78</volume>, <fpage>1158</fpage>-<lpage>1159</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.2006.113514</pub-id><pub-id pub-id-type="pmid">17442758</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rueda</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Flórez</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Martínez-Cué</surname><given-names>C.</given-names></name></person-group> (<year>2008a</year>). <article-title>Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome</article-title>. <source/><italic>Neurosci. Lett.</italic>
<volume>433</volume>, <fpage>22</fpage>-<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2007.12.039</pub-id><pub-id pub-id-type="pmid">18226451</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rueda</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Florez</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Martinez-Cue</surname><given-names>C.</given-names></name></person-group> (<year>2008b</year>). <article-title>Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome</article-title>. <source/><italic>Behav. Brain Res.</italic>
<volume>188</volume>, <fpage>355</fpage>-<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2007.11.020</pub-id><pub-id pub-id-type="pmid">18178265</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rueda</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Llorens-Martín</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Flórez</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Valdizán</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Banerjee</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Trejo</surname><given-names>J. L.</given-names></name> and <name name-style="western"><surname>Martinez-Cué</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>J. Alzheimers Dis.</italic>
<volume>21</volume>, <fpage>277</fpage>-<lpage>290</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-100240</pub-id><pub-id pub-id-type="pmid">20421694</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruf</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Symmons</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Uslu</surname><given-names>V. V.</given-names></name>, <name name-style="western"><surname>Dolle</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Hot</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ettwiller</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Spitz</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>Large-scale analysis of the regulatory architecture of the mouse genome with a transposon-associated sensor</article-title>. <source/><italic>Nat. Genet.</italic>
<volume>43</volume>, <fpage>379</fpage>-<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1038/ng.790</pub-id><pub-id pub-id-type="pmid">21423180</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruiz-Mejias</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Martinez de Lagran</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mattia</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Castano-Prat</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Perez-Mendez</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ciria-Suarez</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Gener</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sancristobal</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>García-Ojalvo</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gruart</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Overexpression of Dyrk1a, a Down Syndrome Candidate, Decreases Excitability and Impairs Gamma Oscillations in the Prefrontal Cortex</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>36</volume>, <fpage>3648</fpage>-<lpage>3659</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2517-15.2016</pub-id><pub-id pub-id-type="pmid">27030752</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sago</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Carlson</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Kilbridge</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>E. M.</given-names></name>, <name name-style="western"><surname>Mobley</surname><given-names>W. C.</given-names></name>, <name name-style="western"><surname>Epstein</surname><given-names>C. J.</given-names></name> and <name name-style="western"><surname>Huang</surname><given-names>T.-T.</given-names></name></person-group> (<year>1998</year>). <article-title>Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>95</volume>, <fpage>6256</fpage>-<lpage>6261</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.11.6256</pub-id><pub-id pub-id-type="pmid">9600952</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahun</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Marechal</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>P. L.</given-names></name>, <name name-style="western"><surname>Nalesso</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Gruart</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Delgado Garcia</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Antonarakis</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Cognition and Hippocampal Plasticity in the Mouse Is Altered by Monosomy of a Genomic Region Implicated in Down Syndrome</article-title>. <source/><italic>Genetics</italic>
<volume>197</volume>, <fpage>899</fpage>-<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.114.165241</pub-id><pub-id pub-id-type="pmid">24752061</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salehi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Delcroix</surname><given-names>J.-D.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Zhan</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Valletta</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Takimoto-Kimura</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kleschevnikov</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Sambamurti</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>P. P.</given-names></name><etal>et al.</etal></person-group> (<year>2006</year>). <article-title>Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration</article-title>. <source/><italic>Neuron</italic>
<volume>51</volume>, <fpage>29</fpage>-<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.05.022</pub-id><pub-id pub-id-type="pmid">16815330</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salehi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Faizi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Colas</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Valletta</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Laguna</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Takimoto-Kimura</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kleschevnikov</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Aisen</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Shamloo</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome</article-title>. <source/><italic>Sci. Transl. Med.</italic>
<volume>1</volume>, <fpage>7ra17</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3000258</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanford</surname><given-names>L. P.</given-names></name>, <name name-style="western"><surname>Kallapur</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ormsby</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Doetschman</surname><given-names>T.</given-names></name></person-group> (<year>2001</year>). <article-title>Influence of genetic background on knockout mouse phenotypes</article-title>. <source/><italic>Methods Mol. Biol.</italic>
<volume>158</volume>, <fpage>217</fpage>-<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1385/1-59259-220-1:217</pub-id><pub-id pub-id-type="pmid">11236659</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sansevero</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Begenisic</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Mainardi</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Sale</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Experience-dependent reduction of soluble beta-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome</article-title>. <source/><italic>Exp. Neurol.</italic>
<volume>283</volume>, <fpage>49</fpage>-<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.06.006</pub-id><pub-id pub-id-type="pmid">27288239</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sebrié</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Chabert</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ledru</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Guedj</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Po</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Rivals</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Beloeil</surname><given-names>J.-C.</given-names></name>, <name name-style="western"><surname>Gillet</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Increased Dosage of DYRK1A and Brain Volumetric Alterations in a YAC Model of Partial Trisomy 21</article-title>. <source/><italic>Anat. Rec. (Hoboken)</italic>
<volume>291</volume>, <fpage>254</fpage>-<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1002/ar.20640</pub-id><pub-id pub-id-type="pmid">18231969</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherman</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>E. G.</given-names></name>, <name name-style="western"><surname>Bean</surname><given-names>L. H.</given-names></name> and <name name-style="western"><surname>Freeman</surname><given-names>S. B.</given-names></name></person-group> (<year>2007</year>). <article-title>Epidemiology of Down syndrome</article-title>. <source/><italic>Ment. Retard. Dev. Disabil. Res. Rev.</italic>
<volume>13</volume>, <fpage>221</fpage>-<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1002/mrdd.20157</pub-id><pub-id pub-id-type="pmid">17910090</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shichiri</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ishida</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Hagihara</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Iwahashi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tamai</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Niki</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>alpha-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Free Radic. Biol. Med.</italic>
<volume>50</volume>, <fpage>1801</fpage>-<lpage>1811</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.03.023</pub-id><pub-id pub-id-type="pmid">21447382</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sittig</surname><given-names>L. J.</given-names></name>, <name name-style="western"><surname>Carbonetto</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Engel</surname><given-names>K. A.</given-names></name>, <name name-style="western"><surname>Krauss</surname><given-names>K. S.</given-names></name>, <name name-style="western"><surname>Barrios-Camacho</surname><given-names>C. M.</given-names></name> and <name name-style="western"><surname>Palmer</surname><given-names>A. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic Background Limits Generalizability of Genotype-Phenotype Relationships</article-title>. <source/><italic>Neuron</italic>
<volume>91</volume>, <fpage>1253</fpage>-<lpage>1259</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.08.013</pub-id><pub-id pub-id-type="pmid">27618673</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>D. J.</given-names></name> and <name name-style="western"><surname>Rubin</surname><given-names>E. M.</given-names></name></person-group> (<year>1997</year>). <article-title>Functional screening and complex traits: human 21q22.2 sequences affecting learning in mice</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>6</volume>, <fpage>1729</fpage>-<lpage>1733</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/6.10.1729</pub-id><pub-id pub-id-type="pmid">9300665</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y. W.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>J. F.</given-names></name> and <name name-style="western"><surname>Rubin</surname><given-names>E. M.</given-names></name></person-group> (<year>1995</year>). <article-title>Construction of a panel of transgenic mice containing a contiguous 2-MB set of YAC/P1 clones from human chromosome 21Q22.2</article-title>. <source/><italic>Genomics</italic>
<volume>27</volume>, <fpage>425</fpage>-<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1006/geno.1995.1073</pub-id><pub-id pub-id-type="pmid">7558023</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>W.-J.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>E.-A. C.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>S.-H.</given-names></name>, <name name-style="western"><surname>Baik</surname><given-names>H.-H.</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>B. K.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J. H.</given-names></name> and <name name-style="western"><surname>Chung</surname><given-names>S.-H.</given-names></name></person-group> (<year>2013</year>). <article-title>Dyrk1A-mediated phosphorylation of RCAN1 promotes the formation of insoluble RCAN1 aggregates</article-title>. <source/><italic>Neurosci. Lett.</italic>
<volume>554</volume>, <fpage>135</fpage>-<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2013.08.066</pub-id><pub-id pub-id-type="pmid">24021800</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>W.-J.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>E.-A. C.</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>M.-S.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>S.-H.</given-names></name>, <name name-style="western"><surname>Baik</surname><given-names>H.-H.</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>B. K.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J. H.</given-names></name> and <name name-style="western"><surname>Chung</surname><given-names>S.-H.</given-names></name></person-group> (<year>2015</year>). <article-title>Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>290</volume>, <fpage>2321</fpage>-<lpage>2333</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.594952</pub-id><pub-id pub-id-type="pmid">25477508</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Souchet</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Guedj</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Sahún</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Daubigney</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Badel</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yanagawa</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Barallobre</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>69</volume>, <fpage>65</fpage>-<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.04.016</pub-id><pub-id pub-id-type="pmid">24801365</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Souchet</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Guedj</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Penke-Verdier</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Daubigney</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Duchon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Herault</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Bizot</surname><given-names>J.-C.</given-names></name>, <name name-style="western"><surname>Janel</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Créau</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Delatour</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models</article-title>. <source/><italic>Front. Behav. Neurosci.</italic>
<volume>9</volume>, <fpage>267</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2015.00267</pub-id><pub-id pub-id-type="pmid">26539088</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stagni</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Magistretti</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Guidi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ciani</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mangano</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Calzà</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Bartesaghi</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>8</volume>, <fpage>e61689</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0061689</pub-id><pub-id pub-id-type="pmid">23620781</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stagni</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Giacomini</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Guidi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ciani</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ragazzi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Filonzi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>De Iasio</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Rimondini</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Bartesaghi</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>74</volume>, <fpage>204</fpage>-<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.12.005</pub-id><pub-id pub-id-type="pmid">25497735</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stagni</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Giacomini</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Emili</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Trazzi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Guidi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sassi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ciani</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Rimondini</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Bartesaghi</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Neuroscience</italic>
<volume>333</volume>, <fpage>277</fpage>-<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.07.031</pub-id><pub-id pub-id-type="pmid">27457036</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stanford</surname><given-names>S. C.</given-names></name></person-group> (<year>2007</year>). <article-title>The Open Field Test: reinventing the wheel</article-title>. <source/><italic>J. Psychopharmacol.</italic>
<volume>21</volume>, <fpage>134</fpage>-<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1177/0269881107073199</pub-id><pub-id pub-id-type="pmid">17329288</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Starbuck</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Dutka</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ratliff</surname><given-names>T. S.</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name> and <name name-style="western"><surname>Richtsmeier</surname><given-names>J. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice</article-title>. <source/><italic>Am. J. Med. Genet. A</italic>
<volume>164</volume>, <fpage>1981</fpage>-<lpage>1990</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36594</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Summers</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Langlois</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wyatt</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>R. D.</given-names></name> and <name name-style="western"><surname>Canada</surname><given-names>S. O. O. A. G. O.</given-names></name></person-group> (<year>2007</year>). <article-title>Prenatal screening for fetal aneuploidy</article-title>. <source/><italic>J. Obstet. Gynaecol. Can.</italic>
<volume>29</volume>, <fpage>146</fpage>-<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/S1701-2163(16)32379-9</pub-id><pub-id pub-id-type="pmid">17346485</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sussan</surname><given-names>T. E.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Ostrowski</surname><given-names>M. C.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome</article-title>. <source/><italic>Nature</italic>
<volume>451</volume>, <fpage>73</fpage>-<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1038/nature06446</pub-id><pub-id pub-id-type="pmid">18172498</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taipale</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Beachy</surname><given-names>P. A.</given-names></name></person-group> (<year>2001</year>). <article-title>The Hedgehog and Wnt signaling pathways in cancer</article-title>. <source/><italic>Nature</italic>
<volume>411</volume>, <fpage>349</fpage>-<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1038/35077219</pub-id><pub-id pub-id-type="pmid">11357142</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tejedor</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>X. R.</given-names></name>, <name name-style="western"><surname>Kaltenbach</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ackermann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Baumann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Canal</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Heisenberg</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fischbach</surname><given-names>K. F.</given-names></name> and <name name-style="western"><surname>Pongs</surname><given-names>O.</given-names></name></person-group> (<year>1995</year>). <article-title>minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila</article-title>. <source/><italic>Neuron</italic>
<volume>14</volume>, <fpage>287</fpage>-<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(95)90286-4</pub-id><pub-id pub-id-type="pmid">7857639</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomazeau</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lassalle</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Iafrati</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Souchet</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Guedj</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Janel</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Chavis</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Delabar</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Manzoni</surname><given-names>O. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>34</volume>, <fpage>1138</fpage>-<lpage>1147</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2852-13.2014</pub-id><pub-id pub-id-type="pmid">24453307</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Threadgill</surname><given-names>D. W.</given-names></name>, <name name-style="western"><surname>Dlugosz</surname><given-names>A. A.</given-names></name>, <name name-style="western"><surname>Hansen</surname><given-names>L. A.</given-names></name>, <name name-style="western"><surname>Tennenbaum</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Lichti</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Yee</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lamantia</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mourton</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Herrup</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Harris</surname><given-names>R. C.</given-names></name></person-group> (<year>1995</year>). <article-title>Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype</article-title>. <source/><italic>Science</italic>
<volume>269</volume>, <fpage>230</fpage>-<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1126/science.7618084</pub-id><pub-id pub-id-type="pmid">7618084</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trazzi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mitrugno</surname><given-names>V. M.</given-names></name>, <name name-style="western"><surname>Valli</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Rizzi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Guidi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Perini</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Bartesaghi</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Ciani</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>, <fpage>1560</fpage>-<lpage>1573</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr033</pub-id><pub-id pub-id-type="pmid">21266456</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trazzi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Valli</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Perini</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Bartesaghi</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Ciani</surname><given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for Down syndrome</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>288</volume>, <fpage>20817</fpage>-<lpage>20829</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.451088</pub-id><pub-id pub-id-type="pmid">23740250</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Troca-Marin</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Alves-Sampaio</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Montesinos</surname><given-names>M. L.</given-names></name></person-group> (<year>2011</year>). <article-title>An increase in basal BDNF provokes hyperactivation of the Akt-mammalian target of rapamycin pathway and deregulation of local dendritic translation in a mouse model of Down's syndrome</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>31</volume>, <fpage>9445</fpage>-<lpage>9455</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0011-11.2011</pub-id><pub-id pub-id-type="pmid">21715609</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Troca-Marín</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Casañas</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Benito</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Montesinos</surname><given-names>M. L.</given-names></name></person-group> (<year>2014</year>). <article-title>The Akt-mTOR pathway in Down's syndrome: the potential use of rapamycin/rapalogs for treating cognitive deficits</article-title>. <source/><italic>CNS Neurol. Disord. Drug Targets</italic>
<volume>13</volume>, <fpage>34</fpage>-<lpage>40</lpage>. <pub-id pub-id-type="doi">10.2174/18715273113126660184</pub-id><pub-id pub-id-type="pmid">24152334</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tybulewicz</surname><given-names>V. L. J.</given-names></name> and <name name-style="western"><surname>Fisher</surname><given-names>E. M.</given-names></name></person-group> (<year>2006</year>). <article-title>New techniques to understand chromosome dosage: mouse models of aneuploidy</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>15</volume>, <fpage>R103</fpage>-<lpage>R109</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddl179</pub-id><pub-id pub-id-type="pmid">16987872</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velazquez</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ash</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Powers</surname><given-names>B. E.</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Strawderman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Luscher</surname><given-names>Z. I.</given-names></name>, <name name-style="western"><surname>Ginsberg</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Mufson</surname><given-names>E. J.</given-names></name> and <name name-style="western"><surname>Strupp</surname><given-names>B. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Neurobiol. Dis.</italic>
<volume>58</volume>, <fpage>92</fpage>-<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.04.016</pub-id><pub-id pub-id-type="pmid">23643842</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vicari</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Motor development and neuropsychological patterns in persons with Down syndrome</article-title>. <source/><italic>Behav. Genet.</italic>
<volume>36</volume>, <fpage>355</fpage>-<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1007/s10519-006-9057-8</pub-id><pub-id pub-id-type="pmid">16505965</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vidal</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>García</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Martínez</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Corrales</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Flórez</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rueda</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Martínez-Cué</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome</article-title>. <source/><italic>Neuroscience</italic>
<volume>220</volume>, <fpage>158</fpage>-<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.06.031</pub-id><pub-id pub-id-type="pmid">22728103</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vilardell</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rasche</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Thormann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Maschke-Dutz</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Pérez-Jurado</surname><given-names>L. A.</given-names></name>, <name name-style="western"><surname>Lehrach</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Herwig</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes</article-title>. <source/><italic>BMC Genomics</italic>
<volume>12</volume>, <fpage>229</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-12-229</pub-id><pub-id pub-id-type="pmid">21569303</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villar</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Gillespie</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Kozy</surname><given-names>H. M.</given-names></name>, <name name-style="western"><surname>Mobley</surname><given-names>W. C.</given-names></name> and <name name-style="western"><surname>Epstein</surname><given-names>C. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Identification and characterization of a new Down syndrome model, Ts Rb(12.17(16)) 2Cje, resulting from a spontaneous Robertsonian fusion between T(17(16))65Dn and mouse Chromosome 12</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>16</volume>, <fpage>79</fpage>-<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-004-2428-7</pub-id><pub-id pub-id-type="pmid">15859352</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Webb</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>R. H.</given-names></name>, <name name-style="western"><surname>Lamers</surname><given-names>W. H.</given-names></name> and <name name-style="western"><surname>Brown</surname><given-names>N. A.</given-names></name></person-group> (<year>1999</year>). <article-title>Mechanisms of deficient cardiac septation in the mouse with trisomy 16</article-title>. <source/><italic>Circ. Res.</italic>
<volume>84</volume>, <fpage>897</fpage>-<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.84.8.897</pub-id><pub-id pub-id-type="pmid">10222336</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiseman</surname><given-names>F. K.</given-names></name>, <name name-style="western"><surname>Al-Janabi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hardy</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Karmiloff-Smith</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Nizetic</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Tybulewicz</surname><given-names>V. L. J.</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>E. M. C.</given-names></name> and <name name-style="western"><surname>Strydom</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome</article-title>. <source/><italic>Nat. Rev. Neurosci.</italic>
<volume>16</volume>, <fpage>564</fpage>-<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3983</pub-id><pub-id pub-id-type="pmid">26243569</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witton</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Padmashri</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Zinyuk</surname><given-names>L. E.</given-names></name>, <name name-style="western"><surname>Popov</surname><given-names>V. I.</given-names></name>, <name name-style="western"><surname>Kraev</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Line</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>T. P.</given-names></name>, <name name-style="western"><surname>Tedoldi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Cummings</surname><given-names>D. M.</given-names></name>, <name name-style="western"><surname>Tybulewicz</surname><given-names>V. L. J.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Hippocampal circuit dysfunction in the Tc1 mouse model of Down syndrome</article-title>. <source/><italic>Nat. Neurosci.</italic>
<volume>18</volume>, <fpage>1291</fpage>-<lpage>1298</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4072</pub-id><pub-id pub-id-type="pmid">26237367</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Ramakrishna</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Wieraszko</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Hwang</surname><given-names>Y.-W.</given-names></name></person-group> (<year>2008</year>). <article-title>Promotion of neuronal plasticity by (−)-epigallocatechin-3-gallate</article-title>. <source/><italic>Neurochem. Res.</italic>
<volume>33</volume>, <fpage>776</fpage>-<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-007-9494-7</pub-id><pub-id pub-id-type="pmid">17943438</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xing</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Salas</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Gittler</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ludwig</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>C.-S.</given-names></name>, <name name-style="western"><surname>Murty</surname><given-names>V. V.</given-names></name>, <name name-style="western"><surname>Silverman</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Arancio</surname><given-names>O.</given-names></name> and <name name-style="western"><surname>Tycko</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1)</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>24</volume>, <fpage>30</fpage>-<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-012-9436-9</pub-id><pub-id pub-id-type="pmid">23096997</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xing</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Pao</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>A. S.</given-names></name>, <name name-style="western"><surname>Tycko</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Mobley</surname><given-names>W. C.</given-names></name> and <name name-style="western"><surname>Yu</surname><given-names>Y. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Mouse-based genetic modeling and analysis of Down syndrome</article-title>. <source/><italic>Br. Med. Bull.</italic>
<volume>120</volume>, <fpage>111</fpage>-<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1093/bmb/ldw040</pub-id><pub-id pub-id-type="pmid">27789459</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Currier</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Poitras</surname><given-names>J. L.</given-names></name> and <name name-style="western"><surname>Reeves</surname><given-names>R. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Increased skin tumor incidence and keratinocyte hyper-proliferation in a mouse model of Down syndrome</article-title>. <source/><italic>PLoS ONE</italic>
<volume>11</volume>, <fpage>e0146570</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0146570</pub-id><pub-id pub-id-type="pmid">26752700</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Bradley</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>Engineering chromosomal rearrangements in mice</article-title>. <source/><italic>Nat. Rev. Genet.</italic>
<volume>2</volume>, <fpage>780</fpage>-<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1038/35093564</pub-id><pub-id pub-id-type="pmid">11584294</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Clapcote</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pao</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bechard</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Carattini-Rivera</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Matsui</surname><given-names>S.-I.</given-names></name>, <name name-style="western"><surname>Roder</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Baldini</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2010a</year>). <article-title>Deficiencies in the region syntenic to human 21q22.3 cause cognitive deficits in mice</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>21</volume>, <fpage>258</fpage>-<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-010-9262-x</pub-id><pub-id pub-id-type="pmid">20512340</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Clapcote</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Asrar</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pao</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2010b</year>). <article-title>A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>19</volume>, <fpage>2780</fpage>-<lpage>2791</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq179</pub-id><pub-id pub-id-type="pmid">20442137</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C. H.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Clapcote</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S. M.</given-names></name>, <name name-style="western"><surname>Pao</surname><given-names>A. N.</given-names></name>, <name name-style="western"><surname>Kleschevnikov</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bechard</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Asrar</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>R. Q.</given-names></name><etal>et al.</etal></person-group> (<year>2010c</year>). <article-title>Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice</article-title>. <source/><italic>Brain Res.</italic>
<volume>1366</volume>, <fpage>162</fpage>-<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.107</pub-id><pub-id pub-id-type="pmid">20932954</pub-id></mixed-citation>
</ref>
<ref id="DMM029728C247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pao</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Belichenko</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Kleschevnikov</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Josselyn</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>P.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits</article-title>. <source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>, <fpage>578</fpage>-<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt446</pub-id><pub-id pub-id-type="pmid">24041763</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>